New Hope for Pradaxa Patients due to Humanized Antibody Fragments

 

humanized antibodies - image credits Wikipedia

 
NOVEMBER 2015 - Pradaxa patients may have a better chance of surviving emergency surgeries, due to a recent study using 5g of idarucizumab (humanized antibody fragments). In critical cases, such as patients with uncontrolled bleeding, intracranial hemmorrhage, or severe trauma following an automobile accident, there is a marginally improved chance for the patient to survive invasive procedures. The specific study mentioned that the timing of the treatment is crucial, such as administering the anticoagulant within four hours. Normal results occurred 92% of the time, under controlled circumstances in the study from Boehringer Ingelheim. Results of the study were presented at the European Society of Cardiology Congress 2015.
 
Legal Commentary
Our Pradaxa attorneys at Fears Nachawati are studying, examining and investigating current Pradaxa claims on behalf of patients and their families who may have been injured by the drug. If you or a loved one has experienced any side effects while taking Pradaxa, contact our Pradaxa lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at +1.866.694.6774 or by email at mn@fnlawfirm.com.
 
About the Author
Majed Nachawati is a dedicated Pradaxa Lawyer who is focused on representing victims and families harmed by dangerous drugs nationwide. Mr. Nachawati has resolved numerous medication cases successfully, with proven results, such as seven and eight figure confidential settlements. Texas Monthly Magazine recognized Mr. Nachawati as a Super Lawyer for the past six years. He is a member of many prominent legal organizations, including: the Grievance Committee for the State Bar of Texas, Board of Directors of the Texas Trial Lawyers Association, Board of Directors for Public Justice, PAC member of the American Association for Justice, a Leaders' Forum, and the Million Dollar Advocates Forum. Mr. Nachawati is licensed to practice in the Northern, Southern, and Eastern Districts of Texas. Contact Majed Nachawati through his website http://bloodthinnerlawfirm.com, by email at mn@fnlawfirm.com or by calling +1.866.694.6774

Xarelto Trial Dates Set in Early 2017

NOVEMBER 2015 - Four trial dates are set for early 2017 for the consolidated multidistrict litigation (MDL) against Bayer AG and a Johnson and Johnson subsidiary regarding injuries sustained by Xarelto patients. U.S. District Judge Eldon Fallon in the Eastern District of Louisiana issued the order for trial dates of February 6, 2017 and March 13, 2017. Mississippi's Xarelto trials will be held on April 24, 2017. In Texas, the Xarelto trial will occur on May 30, 2017. The MDL allows the large number of individual cases of Xarelto injuries to benefit from certain streamlined class action processes, without becoming a class, including pre-trial motions, discovery, and settlement conferences. All plaintiffs will reap the benefits of all of the available evidence. The consolidated lawsuits allege that Xarelto causes severe internal bleeding, serious injuries, and death.

 
Legal Commentary
Fears Nachawati's Xarelto attorneys are studying, examining and investigating Xarelto claims on behalf of people and their families who may have been injured by the drug. Although no monetary amount can compensate for the loss of a loved one, a successful claim against the responsible parties will enable the victim’s family to cover any medical or final expenses, so that they may focus on the grieving process during this trying time. If you or a loved one experienced any side effects while taking Xarelto, contact our Xarelto lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at +1.866.813.1662 or by email at mn@fnlawfirm.com.
 
About the Author
Majed Nachawati is a dedicated Xarelto Lawyer who represents victims and families harmed by dangerous drugs nationwide. Mr. Nachawati has resolved numerous pharmaceutical cases successfully, resulting in seven and eight figure confidential settlements. Texas Monthly Magazine named him as a Super Lawyer for the past six years. He is a member of a Leaders' Forum and a Board of Directors member for the Texas Trial Lawyers Association. He is also a member of the Board of Directors for Public Justice, a PAC member of the American Association for Justice, and the Grievance Committee for the State Bar of Texas. Mr. Nachawati holds licenses to practice law in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati can be reached through his website at http://cases.fnlawfirm.com/xarelto, by email at mn@fnlawfirm.com or by calling +1.866.813.1662.

Xarelto Lawsuits Multiply in 2015

 

NOVEMBER 2015 - Additional lawsuits filed this year in Ohio and Pennsylvania allege that the blood thinner drug Xarelto is causing serious injuries and death to patients nationwide. Xarelto has been proven to cause complications, such as: excessive bleeding, red or black stools, frequent nosebleeds, pink or brown urine, unexplained bruises, bruises that increase in size, coughing up blood or blood clots, vomiting blood or vomit that resembles coffee grounds, bleeding from the gums, excessive menstruation and death. The Xarelto lawsuits are planned for multidistrict litigation in 2017 in the US District Court, Eastern District of Louisiana. The Ohio case was filed on October 5 and the Philadelphia case was filed October 8. 
 
Legal Commentary
Fears Nachawati's Xarelto attorneys are studying, examining and investigating Xarelto claims on behalf of people and their families who may have been injured by the drug. Although no monetary amount can compensate for the loss of a loved one, a successful claim against the responsible parties will enable the victim’s family to cover any medical or final expenses, so that they may focus on the grieving process during this trying time. If you or a loved one experienced any side effects while taking Xarelto, contact our Xarelto lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at +1.866.813.1662 or by email at mn@fnlawfirm.com.
 
About the Author
Majed Nachawati is a dedicated Xarelto Lawyer who represents victims and families harmed by dangerous drugs nationwide. Mr. Nachawati has resolved numerous pharmaceutical cases successfully, resulting in seven and eight figure confidential settlements. Texas Monthly Magazine named him as a Super Lawyer for the past six years. He is a member of a Leaders' Forum and a Board of Directors member for the Texas Trial Lawyers Association. He is also a member of the Board of Directors for Public Justice, a PAC member of the American Association for Justice, and the Grievance Committee for the State Bar of Texas. Mr. Nachawati holds licenses to practice law in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati can be reached through his website at http://cases.fnlawfirm.com/xarelto, by email at mn@fnlawfirm.com or by calling +1.866.813.1662.

Will Praxbind Reign as a Safe Antidote to Pradaxa?

 

OCTOBER 2015 - Although there is still no antidote for Xarelto or Eliquis, the European Medicines Agency (EMA) is fast-tracking Praxbind as an antidote for the blood thinner Pradaxa. Pradaxa patients have been injured and dying due to the anticoagulant causing uncontrollable bleeding in emergencies. The life-threatening risk of uncontrolled bleeding is a constant threat to Pradaxa patients. The Committee for Medicinial Products for Human Use (CHMP) recommended marketing authorization after its rapid assessment of Praxbind. The study resulted in reveral of Pradaxa's anticoagulant effect 5 minutes after the patients in the Praxbind drug study took the antidote.
 
 
Legal Commentary
Fears Nachawati's Pradaxa attorneys are studying, examining and investigating Pradaxa claims on behalf of people and their families who may have been injured by the drug. Although no monetary amount can compensate for the loss of a loved one, a successful claim against the responsible parties will enable the victim’s family to cover any medical or final expenses, so that they may focus on the grieving process during this trying time. If you or a loved one experienced any side effects while taking Pradaxa, contact our Pradaxa lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at +1.866.813.1662 or by email at mn@fnlawfirm.com.
 
About the Author
Majed Nachawati is a dedicated Pradaxa Lawyer who represents victims and families harmed by dangerous drugs nationwide. Mr. Nachawati has resolved numerous pharmaceutical cases successfully, resulting in seven and eight figure confidential settlements. Texas Monthly Magazine named him as a Super Lawyer for the past six years. He is a member of a Leaders' Forum and a Board of Directors member for the Texas Trial Lawyers Association. He is also a member of the Board of Directors for Public Justice, a PAC member of the American Association for Justice, and the Grievance Committee for the State Bar of Texas. Mr. Nachawati holds licenses to practice law in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati can be reached through his website at bloodthinnerlawfirm.com, by email at mn@fnlawfirm.com or by calling +1.866.813.1662.

Xarelto Advertisements Failed to Disclose the Reality of Risks, Lawsuit Alleges

 

OCTOBER 2015 - Many Xarelto lawsuits that have been filed against Johnson & Johnson and Bayer Corporation allege that the pharmaceutical companies failed to disclose the reality of the blood thinner's risks and dangers. Xarelto has been prescribed as a blood thinner to treat many conditions, from nonvalvular atrial fibrillation, deep vein thrombosis, to pulmonary embolism. The favorable studies that center on the drug's positive outcomes are also at question, due to the many cases of uncontrolled bleeding that sometimes lead to death in Xarelto patients nationwide. Other patients have suffered strokes, retinal hemorrhages, epidural hematoma, intracranial hemorrhages, hemoglobin decrease, gastrointestinal hemorrhages, and adrenal bleeding.
 
Legal Commentary
Fears Nachawati's Xarelto attorneys are studying, examining and investigating Xarelto claims on behalf of people and their families who may have been injured by the drug. Although no monetary amount can compensate for the loss of a loved one, a successful claim against the responsible parties will enable the victim’s family to cover any medical or final expenses, so that they may focus on the grieving process during this trying time. If you or a loved one experienced any side effects while taking Xarelto, contact our Xarelto lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at +1.866.813.1662 or by email at mn@fnlawfirm.com.
 
About the Author
Majed Nachawati is a dedicated Xarelto Lawyer who represents victims and families harmed by dangerous drugs nationwide. Mr. Nachawati has resolved numerous pharmaceutical cases successfully, resulting in seven and eight figure confidential settlements. Texas Monthly Magazine named him as a Super Lawyer for the past six years. He is a member of a Leaders' Forum and a Board of Directors member for the Texas Trial Lawyers Association. He is also a member of the Board of Directors for Public Justice, a PAC member of the American Association for Justice, and the Grievance Committee for the State Bar of Texas. Mr. Nachawati holds licenses to practice law in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati can be reached through his website at http://cases.fnlawfirm.com/xarelto, by email at mn@fnlawfirm.com or by calling +1.866.813.1662.
 

What Can We Do About Risperdal's Side Effects?

 

OCTOBER 2015 - Last month, Huffington Post published a 58,000 word series on Johnson & Johnson's illegal marketing of the dangerous drug Risperdal. Risperdal is proven to cause young boys to grow large breasts. The series exposes unethical and illegal behavior from Johnson and Johnson since Risperdal's release in 1994. We can all take steps to ensure that Johnson & Johnson is accountable for manufacturing and selling dangerous drugs. As an informed consumer, each one of us can avoid drugs produced by such companies, who have long histories of questionable methods. Read the labels of all drugs, both prescription drugs and over-the-counter drugs. Ask your doctor about other options for drugs that are not promoted or sold by companies that have outstanding litigation. Most importantly, you can bring these issues to light in litigation by filing a lawsuit when you or one of your loved ones is harmed by a dangerous drug.
 
Legal Commentary
The antipsychotic drug Risperdal has been linked to breast development in young boys. Psychopharmacology published first study results in January 1999, associating Risperdal with gynecomastia. The study reported Risperdal caused gynecomastia when used in conjunction with the antidepressant Prozac, which contains fluoxetine. Patients who have developed Risperdal gynecomastia are encouraged to speak with an experienced pharmaceutical injury attorney immediately. Risperdal has been proven to cause breast development in young boys, or pituitary cancer and tumors. Other symptoms of Risperdal caused gynecomastia include pain, tenderness, or swelling of the breasts, and/or nipple discharge. Gynecomastia can be emotionally and psychologically damaging, and may require surgical correction. If you or a loved one took Risperdal to treat bipolar disorder, schizophrenia, or behavioral issues associated with autism, you may be entitled to cash compensation. Contact our team of attorneys today by email or phone at +1.888.545.7402 for a free evaluation of your case today.
 
About the Author
Majed Nachawati is a dedicated Risperdal Lawyer who represents victims and families harmed by dangerous drugs nationwide. Mr. Nachawati has resolved numerous pharmaceutical cases successfully, resulting in seven and eight figure confidential settlements. Texas Monthly Magazine named him as a Super Lawyer for the past six years. He is a member of a Leaders' Forum and a Board of Directors member for the Texas Trial Lawyers Association. He is also a member of the Board of Directors for Public Justice, a PAC member of the American Association for Justice, and the Grievance Committee for the State Bar of Texas. Mr. Nachawati holds licenses to practice law in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati can be reached through his website at http://cases.fnlawfirm.com/gynecomastia, by email at mn@fnlawfirm.com or by calling +1.888.545.7402

Washington Post Exposes FDA's Questionable Decisions Regarding Praxada

 

OCTOBER 2015 - The Washington Post published an article recently reporting concerns that the FDA did not adequately review the safety and risks of the Pradaxa blood thinner. Reports of Pradaxa injuries are coming in daily to our office, including an Indiana man who has been taking Pradaxa since 2013, and now has blood in his urine, a Vermont woman who took Pradaxa since 2011 and now has internal bleeding, and a Michigan woman who took Pradaxa since 2014 and developed uncontrolled internal bleeding less than a year later. The Post's article explained how the Project on Government Oversight (POGO) is investigating to determine if the warnings provided to patients were adequate. The article concluded that two members of the FDA advisory committee that made decisions regarding FDA approval of Pradaxa are partnered financially with Boehringer Ingelheim, Pradaxa's manufacturer.
 
Legal Commentary
Fears Nachawati's Pradaxa attorneys are studying, examining and investigating Pradaxa claims on behalf of people and their families who may have been injured by the drug. Although no monetary amount can compensate for the loss of a loved one, a successful claim against the responsible parties will enable the victim’s family to cover any medical or final expenses, so that they may focus on the grieving process during this trying time. If you or a loved one experienced any side effects while taking Pradaxa, contact our Pradaxa lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at +1.866.813.1662 or by email at mn@fnlawfirm.com.
 
About the Author
Majed Nachawati is a dedicated Pradaxa Lawyer who represents victims and families harmed by dangerous drugs nationwide. Mr. Nachawati has resolved numerous pharmaceutical cases successfully, resulting in seven and eight figure confidential settlements. Texas Monthly Magazine named him as a Super Lawyer for the past six years. He is a member of a Leaders' Forum and a Board of Directors member for the Texas Trial Lawyers Association. He is also a member of the Board of Directors for Public Justice, a PAC member of the American Association for Justice, and the Grievance Committee for the State Bar of Texas. Mr. Nachawati holds licenses to practice law in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati can be reached through his website at bloodthinnerlawfirm.com, by email at mn@fnlawfirm.com or by calling +1.866.813.1662.

Recent Xarelto Study Reveals Drug Manufacturer Agenda to Minimize Reports of Deaths and Injuries

 blood thinner Xarelto causes uncontrollable bleeding and death in many Xarelto patients

OCTOBER 2015 - Jasnssen Pharmaceuticals, Inc. published a recent study on the safety of Xarelto, where the drug manufacturer attempted to minimize the injuries and uncontrolled bleeding that Xarelto patients are suffering globally. Over 45,000 patients participated in the study. Janssen and the marketing firm that assisted with the study concluded that almost 3 out of 100 Xarelto patients experienced major bleeding. Our reports show that the issues with bleeding hemorrhaging, stroke, and death are critical, and should not be understated.
 
Just this week, we have heard from the following individuals regarding their personal struggles after taking Xarelto. Even worse, we hear daily from the loved ones of former Xarelto patients who lost their battle with uncontrolled bleeding and died after taking the blood thinner.
 
The top five most recent reports include:
 
  • A Louisiana woman who took Xarelto 6 months, and then she began uncontrollable bleeding from her rectum
  • A California woman who had to be hospitalized from excessive bleeding after taking Xarelto
  • A Texas man who developed blood in his urine and internal bleeding from Xarelto use
  • A Wisconsin woman who died from internal bleeding after taking Xarelto
  • A Texas woman who suffered from a stroke after taking Xarelto
 
Legal Commentary
Fears Nachawati's Xarelto attorneys are studying, examining and investigating Xarelto claims on behalf of people and their families who may have been injured by the drug. Although no monetary amount can compensate for the loss of a loved one, a successful claim against the responsible parties will enable the victim’s family to cover any medical or final expenses, so that they may focus on the grieving process during this trying time. If you or a loved one experienced any side effects while taking Xarelto, contact our Xarelto lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at +1.866.813.1662 or by email at mn@fnlawfirm.com.
 
About the Author
Majed Nachawati is a dedicated Xarelto Lawyer who represents victims and families harmed by dangerous drugs nationwide. Mr. Nachawati has resolved numerous pharmaceutical cases successfully, resulting in seven and eight figure confidential settlements. Texas Monthly Magazine named him as a Super Lawyer for the past six years. He is a member of a Leaders' Forum and a Board of Directors member for the Texas Trial Lawyers Association. He is also a member of the Board of Directors for Public Justice, a PAC member of the American Association for Justice, and the Grievance Committee for the State Bar of Texas. Mr. Nachawati holds licenses to practice law in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati can be reached through his website at http://cases.fnlawfirm.com/xarelto, by email at mn@fnlawfirm.com or by calling +1.866.813.1662.

Inside Story Behind Johnson & Johnson's Risperdal 20 Year Cover Up

SEPTEMBER 2015 - Huffington Post has published "The Miracle Industry Series," where the news outlet reveals that Johnson & Johnson spent 20 years marketing the drug Risperdal to children and the elderly. Once again, pharmaceutical profits won out over safety and the truth about the side effects. Huffington Post reveals that Johnson & Johnson's "strategies, tactics, and mindset should make us wonder about the prescription drugs that are so much a part of our lives." Chapter 15 of the series is due to be released on September 29, 2015. Chapter 1 starts here: http://highline.huffingtonpost.com/miracleindustry/americas-most-admired-lawbreaker/chapter-1.html
 
Legal Commentary
The antipsychotic drug Risperdal has been linked to breast development in young boys. Psychopharmacology published first study results in January 1999, associating Risperdal with gynecomastia. The study reported Risperdal caused gynecomastia when used in conjunction with the antidepressant Prozac, which contains fluoxetine. Patients who have developed Risperdal gynecomastia are encouraged to speak with an experienced pharmaceutical injury attorney immediately. Risperdal has been proven to cause breast development in young boys, or pituitary cancer and tumors. Other symptoms of Risperdal caused gynecomastia include pain, tenderness, or swelling of the breasts, and/or nipple discharge. Gynecomastia can be emotionally and psychologically damaging, and may require surgical correction. If you or a loved one have taken Risperdal to treat bipolar disorder, schizophrenia, or behavioral issues associated with autism, you may be entitled to cash compensation. Contact our team of attorneys today by email or phone at +1.888.545.7402 for a free evaluation of your case today.
 
About the Author
Majed Nachawati is a dedicated Risperdal Lawyer who represents victims and families harmed by dangerous drugs nationwide. Mr. Nachawati has resolved numerous pharmaceutical cases successfully, resulting in seven and eight figure confidential settlements. Texas Monthly Magazine named him as a Super Lawyer for the past six years. He is a member of a Leaders' Forum and a Board of Directors member for the Texas Trial Lawyers Association. He is also a member of the Board of Directors for Public Justice, a PAC member of the American Association for Justice, and the Grievance Committee for the State Bar of Texas. Mr. Nachawati holds licenses to practice law in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati can be reached through his website at http://cases.fnlawfirm.com/gynecomastia, by email at mn@fnlawfirm.com or by calling +1.888.545.7402

Canadian Government Agrees on the Dangers of Xarelto Use

 

SEPTEMBER 2015 - Although the U.S. FDA approved Xarelto in 2011, many patients have experienced liver injuries and uncontrolled bleeding, resulting in severe damage and even death in some cases. In August, 2015, Canadian regulators announced an official investigation into numerous reports of liver injuries due to Xarelto use. The report states, "This issue was identified after two publications in the scientific literature described liver injury linked to the use of XARELTO in a total of 16 patients." Canada is not far behind the U.S. in its assessment of the health risks associated with Xarelto use.
 
Legal Commentary
Fears Nachawati's Xarelto attorneys are studying, examining and investigating Xarelto claims on behalf of people and their families who may have been injured by the drug. Although no monetary amount can compensate for the loss of a loved one, a successful claim against the responsible parties will enable the victim’s family to cover any medical or final expenses, so that they may focus on the grieving process during this trying time. If you or a loved one experienced any side effects while taking Xarelto, contact our Xarelto lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at +1.866.813.1662 or by email at mn@fnlawfirm.com.
 
About the Author
Majed Nachawati is a dedicated Xarelto Lawyer who represents victims and families harmed by dangerous drugs nationwide. Mr. Nachawati has resolved numerous pharmaceutical cases successfully, resulting in seven and eight figure confidential settlements. Texas Monthly Magazine named him as a Super Lawyer for the past six years. He is a member of a Leaders' Forum and a Board of Directors member for the Texas Trial Lawyers Association. He is also a member of the Board of Directors for Public Justice, a PAC member of the American Association for Justice, and the Grievance Committee for the State Bar of Texas. Mr. Nachawati holds licenses to practice law in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati can be reached through his website at http://cases.fnlawfirm.com/xarelto by email at mn@fnlawfirm.com or by calling +1.866.813.1662.

Benicar Can Damage the Small Intestine

 Benicar Dangerous Side Effects

SEPTEMBER 2015 - Dr. Joseph Murray of the May Clinic has linked the condition sprue-like enteropathy to Benicar, a medication for high blood pressure. The list of symptoms and side effects related to Benicar use is growing. The small intestine can become damaged to the point where it cannot absorb nutrients effectively after Benicar use. Next, chronic diarrhea sets in, and kidney damage. Even more troubling, Benicar use can lead to erosion of the small intestine. These severe issues are compounded with the other Benicar side effects, such as nausea, vomiting, headaches, dizziness, problems swallowing, and difficulty breathing.
 
Legal Commentary
Fears Nachawati's Benicar attorneys are studying, examining and investigating Benicar claims on behalf of people and their families who may have been injured by the drug. Although no monetary amount can compensate for the loss of a loved one, a successful claim against the responsible parties will enable the victim’s family to cover any medical or final expenses, so that they may focus on the grieving process during this trying time. If you or a loved one experienced any side effects while taking Xarelto, contact our Benicar attorneys to discuss the facts of your potential case. We are available by phone for a free consultation at +1.866.705.7584 or by email.
 
About the Author
Majed Nachawati is a dedicated Xarelto Lawyer who represents victims and families harmed by dangerous drugs nationwide. Mr. Nachawati has resolved numerous pharmaceutical cases successfully, resulting in seven and eight figure confidential settlements. Texas Monthly Magazine named him as a Super Lawyer for the past six years. He is a member of a Leaders' Forum and a Board of Directors member for the Texas Trial Lawyers Association. He is also a member of the Board of Directors for Public Justice, a PAC member of the American Association for Justice, and the Grievance Committee for the State Bar of Texas. Mr. Nachawati holds licenses to practice law in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati can be reached through his website at http://fnlawfirm.com/practice-area/drug-litigation by email at mn@fnlawfirm.com or by calling +1.866.705.7584.

Uncontrollable Bleeding After Pradaxa Use can Lead to Death

 Pradaxa

SEPTEMBER 2015 - Pradaxa is a prescription blood thinner medicine that lowers the chance of blood clots forming in your body. It is commonly prescribed to reduce the risk of stroke and blood clots in patients with Atrial Fibrillation that is not caused by a heart valve problem. Pradaxa is also used to treat blood clots in the veins of the legs (Deep vein thrombosis, or DVT) or lungs (Pulmonary Embolism, or PE) and to reduce the risk of clots occurring again. However, the popular blood thinner medication has caused severe internal injuries and death in users. Here are just a few of the stories that came into our office recently from patients and families who have been injured by Pradaxa use:
 
  • A woman in Virginia died after taking Pradaxa for 5 years. She suffered from intracranial bleeding at the time of death.
  • a Colorado man developed uncontrolled internal bleeding after taking Pradaxa for 2 months
  • An Alabama man took Pradaxa for only one month and developed bloody stools, unexpected bleeding, and internal bleeding
  • A Florida woman died of GI hemorrhaging after taking Pradaxa for 7 months. Her doctors could not stop the bleeding during surgery, and she passed away in hospice care shortly thereafter.
Legal Commentary
Our Pradaxa attorneys at Fears Nachawati are studying, examining and investigating current Pradaxa claims on behalf of patients and their families who may have been injured by the drug. If you or a loved one has experienced any side effects while taking Pradaxa, contact our Pradaxa lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at +1.866.694.6774 or by email at mn@fnlawfirm.com.
 
About the Author
Majed Nachawati is a dedicated Pradaxa Lawyer who is focused on representing victims and families harmed by dangerous drugs nationwide. Mr. Nachawati has resolved numerous medication cases successfully, with proven results, such as seven and eight figure confidential settlements. Texas Monthly Magazine recognized Mr. Nachawati as a Super Lawyer for the past six years. He is a member of many prominent legal organizations, including: the Grievance Committee for the State Bar of Texas, Board of Directors of the Texas Trial Lawyers Association, Board of Directors for Public Justice, PAC member of the American Association for Justice, a Leaders' Forum, and the Million Dollar Advocates Forum. Mr. Nachawati is licensed to practice in the Northern, Southern, and Eastern Districts of Texas. Contact Majed Nachawati through his website http://bloodthinnerlawfirm.com/, by email at mn@fnlawfirm.com or by calling +1.866.694.6774

 

Teen Dies After 3 months of Xarelto Use

 

MISSION HILLS, CA - Sean David Pulskamp died tragically after taking Xarelto for three months. The cause of death was listed as cardiopulmonary arrest, pulmonary embolism, deep vein thrombosis, and pulmonary hypertension. Mr. Pulskamp was only 19 years old.

Growing concerns over deaths and complications from blood thinners like Xarelto are forcing leading cardiologists to reconsider prescribing them. These risks and trends should not be ignored. Patients nationwide are reporting serious life-threatening issues after taking Xarelto, such as uncontrolled internal bleeding, hemorrhaging, stroke and/or death.

Legal Commentary
Fears Nachawati's Xarelto attorneys are studying, examining and investigating Xarelto claims on behalf of people and their families who may have been injured by the drug. Although no monetary amount can compensate for the loss of a loved one, a successful claim against the responsible parties will enable the victim’s family to cover any medical or final expenses, so that they may focus on the grieving process during this trying time. If you or a loved one experienced any side effects while taking Xarelto, contact our Xarelto lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at +1.866.813.1662 or by email at mn@fnlawfirm.com.

About the Author
Majed Nachawati is a dedicated Xarelto Lawyer who represents victims and families harmed by dangerous drugs nationwide. Mr. Nachawati has resolved numerous pharmaceutical cases successfully, resulting in seven and eight figure confidential settlements. Texas Monthly Magazine named him as a Super Lawyer for the past six years. He is a member of a Leaders' Forum and a Board of Directors member for the Texas Trial Lawyers Association. He is also a member of the Board of Directors for Public Justice, a PAC member of the American Association for Justice, and the Grievance Committee for the State Bar of Texas. Mr. Nachawati holds licenses to practice law in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati can be reached through his website at http://cases.fnlawfirm.com/xarelto/ by email at mn@fnlawfirm.com or by calling +1.866.813.1662.

Blood Thinner Pradaxa Causing Serious Health Complications and Death

 

AUGUST 2015  - Anticoagulant Pradaxa is a blood thinner designed to prevent blood clots. The dangerous side effects and complications from taking Pradaxa are injuring and killing patients nationwide. The risks and serious health complications caused by this blood thinner have been reported in many leading medical journals and studies. Pradaxa can lead to a 35% increase in the risk of GI bleeding. Almost 17% of all Pradaxa patients experienced uncontrollable bleeding. Here are some of their tragic stories:

  • Colorado man, 77, who died of kidney failure after taking Pradaxa for 3 years
  • Texas man, 71, who suffered from Gastrointestinal Bleeding, Retinal Bleeding, and Rectal Bleeding before he died after taking Pradaxa for less than a year
  • 79-year-old Texas woman, who died after taking Pradaxa for 3 years. Before her death, she suffered kidney issues, blood clots, gastrointestinal bleeding, retinal bleeding, vaginal bleeding, liver issues, and a stroke.
  • A 68-year-old mother of two from Ohio took Pradaxa for 6 months before she died. She suffered coughing blood, vomiting blood, blood in her stools, and internal bleeding.
Legal Commentary
Our Pradaxa attorneys at Fears Nachawati are studying, examining and investigating current Pradaxa claims on behalf of patients and their families who may have been injured by the drug. If you or a loved one has experienced any side effects while taking Pradaxa, contact our Pradaxa lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at +1.866.694.6774 or by email at mn@fnlawfirm.com.
 
About the Author
Majed Nachawati is a dedicated Pradaxa Lawyer focused on representing victims and families harmed by dangerous drugs nationwide. Mr. Nachawati has resolved numerous medication cases successfully, with proven results, such as seven and eight figure confidential settlements. Texas Monthly Magazine recognized Mr. Nachawati as a Super Lawyer for the past six years. He is a member of many prominent legal organizations, including: the Grievance Committee for the State Bar of Texas, Board of Directors of the Texas Trial Lawyers Association, Board of Directors for Public Justice, PAC member of the American Association for Justice, a Leaders' Forum, and the Million Dollar Advocates Forum. Mr. Nachawati is licensed to practice in the Northern, Southern, and Eastern Districts of Texas. Contact Majed Nachawati through his website http://bloodthinnerlawfirm.com/, by email at mn@fnlawfirm.com or by calling +1.866.694.6774

Two Recent Studies Question Xarelto's Safety

Xarelto, the blockbuster anticoagulant that was approved by the FDA in 2011, has continued to come under scrutiny by parts of the medical community. Initially, the drug was approved to help reduce the risk of blood clots in patients who had undergone knee or hip replacement. Later, Xarelto was approved to help patients with deep vein thrombosis (DVT) and pulmonary embolism. Unfortunately, hundreds of patients who have taken the drug have experience negative side effects, including uncontrollable internal bleeding that has no antidote. 

One recent study, led by doctors Judy H. Hun and John C. Hwang, linked usage of the drug to an increased incidence of spontaneous vitreous hemorrhage, or eye bleeding, and noted that it was most notable when patients switched from one blood thinner to Xarelto. A second study compared the safety of Xarelto and Pradaxa to warfarin, the more traditional anticoagulant in the market today. Their study suggested a link between Xarelto and Pradaxa usage to a 50% increased risk of gastrointestinal bleeding. There are more than 500 Xarelto-related lawsuits pending in consolidated state and federal courts.

Legal Commentary
Xarelto attorneys within our firm are studying, examining and investigating current Xarelto claims on behalf of people and their families who may have been injured by the drug. Some of the side effects include hemorrhaging, internal bleeding, stroke and or death. If you or a loved one has experienced any side effects while taking Xarelto, contact our Xarelto lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at 1.866.705.7584 or by email at mn@fnlawfirm.com.

About the Author
Majed Nachawati is a dedicated Xarelto Lawyer with a focus on representing victims and families harmed by this dangerous drug on a nationwide basis. Mr. Nachawati has resolved numerous dangerous drug medication cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past six consecutive years for legal excellence, in connection with noteworthy settlements for pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584. 

Doctor With Ties to Drug Companies At Center of Increased Sales of Anticoagulants

A new generation of anticoagulants, namely Xarelto and Pradaxa, have been at the center of much controversy in recent times. The manufacturers of these drugs have seen a significant increase in sales of their drugs, thanks in part to how convenient they are compared to more traditional blood thinners. However, the significant sales of these drugs can also be linked to Gregory Lip, a British heart doctor who has extensive ties to the pharmaceutical industry.

Lip has been a paid speaker and consultant for these manufacturers for many years and has also served on treatment guidelines panels, most of which have recommended that more people use these new drugs. One scale in particular, adopted in the U.S. in 2014, suggested than an additional 1 million people take the drug. However, external experts warn that the scale can lead to people with a lower or intermediate risk being put on these newer anticoagulants and risk internal bleeding.

According to the Milwaukee Journal Sentinel/MedPage Today, Lip has received money from at least 5 companies that market and/or make these new anticoagulants. As a British citizen, Lip does not have to disclose the amount of money he has received. However, his connection to these drug companies illustrates how doctors can be easily influenced and make suggestions that are not at the best interest of their patients or the general population. 

Legal Commentary
Xarelto and Pradaxa attorneys within our firm are studying, examining and investigating current Xarelto and Pradaxa claims on behalf of people and their families who may have been injured by the drug. Some of the side effects include hemorrhaging, internal bleeding, stroke and or death. If you or a loved one has experienced any side effects while taking Xarelto or Pradaxa, contact our Xarelto and Pradaxa lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at 1.866.705.7584 or by email at mn@fnlawfirm.com.

About the Author
Majed Nachawati is a dedicated Xarelto Lawyer with a focus on representing victims and families harmed by this dangerous drug on a nationwide basis. Mr. Nachawati has resolved numerous dangerous drug medication cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past six consecutive years for legal excellence, in connection with noteworthy settlements for pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.

New Evidence Shows that Xarelto Can Be Passed Down From Mother to Fetus

A recent study has revealed that mothers who take Xarelto can pass down the drug to their unborn child. When ingested during pregnancy, the anticoagulant transfers back and forth across the placenta between a mother and her fetus. The study was done by a research team at The Motherisk Program at the Hospital for Sick Children in Toronto and published most recently in the American Journal of Obstetrics & Gynecology. They initially began the study in order to discover the degree of transfer of the drug and what potential side effects would occur.

Although they were able to prove that Xarelto did transfer from a mother to her fetus, they will need to conduct additional studies to better understand whether or not it would be safe to administer Xarelto to a pregnant woman. In some high-risk pregnancies, anti-coagulants are a necessary treatment for expecting mothers. Unfortunately, Xarelto does not yet have an antidote and if it is given to pregnant women, it may pose a risk for her fetus. For this reason, researchers have indicated that further studies are needed to better understand this risk. 

Legal Commentary
Xarelto attorneys within our firm are studying, examining and investigating current Xarelto claims on behalf of people and their families who may have been injured by the drug. Some of the side effects include hemorrhaging, internal bleeding, stroke and or death. If you or a loved one has experienced any side effects while taking Xarelto, contact our Xarelto lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at 1.866.705.7584 or by email at mn@fnlawfirm.com.

About the Author
Majed Nachawati is a dedicated Xarelto Lawyer with a focus on representing victims and families harmed by this dangerous drug on a nationwide basis. Mr. Nachawati has resolved numerous dangerous drug medication cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past six consecutive years for legal excellence, in connection with noteworthy settlements for pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.

New Study Claims That New Drug Can Reverse Effects of Blood Thinner Pradaxa

A new experimental drug has been proven to reverse the effects of the drug Pradaxa (dabigatran). The drug, called idarucizumab, is said to work within minutes of being given to patients. Pradaxa is a newer anticoagulant that has been marketed as an easier alternative to traditional blood thinners. Unfortunately, it was not created alongside an antidote that could undo the potentially deadly side effects that Pradaxa can produce, particularly uncontrollable bleeding. The new antidote has been shown to bind to Pradaxa, neutralizing its activity and immediately restoring normal blood clotting. 

The study was published by the New England Journal of Medicine and was led by Charles Pollack, a chair of emergency medicine at Pennsylvania Hospital. It is currently ongoing and is being conducted at various hospitals in 38 countries. However, researchers warn that the antidote is imperfect: it is designed to treat patients who cannot wait one to two days for Pradaxa to clear out of their bodies. Idarucizumab has not yet been approved by the U.S. Food and Drug Administration and given that the study is still in progress, it may be some time before an antidote to newer anticoagulants is available.

 

Legal Commentary
Pradaxa attorneys within our firm are studying, examining and investigating current Pradaxa claims on behalf of people and their families who may have been injured by the drug. Some of the side effects include hemorrhaging, internal bleeding, stroke and or death. If you or a loved one has experienced any side effects while taking Pradaxa, contact our Pradaxa lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at 1.866.705.7584 or by email at mn@fnlawfirm.com.

About the Author
Majed Nachawati is a dedicated Pradaxa Lawyer with a focus on representing victims and families harmed by this dangerous drug on a nationwide basis. Mr. Nachawati has resolved numerous dangerous drug medication cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past six consecutive years for legal excellence, in connection with noteworthy settlements for pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.
 

 

Xarelto Multidistrct Litigation Sets Bellwether Trial Dates for 2016

Since December 2014, all federal Xarelto lawsuits have been consolidated in the Eastern District of Louisiana. Any federal lawsuits filed against Janssen Pharmaceuticals and Bayer AG, the manufacturers of Xarelto (rivaroxaban), would have been transferred to the Louisiana court for pre-trial proceedings. By moving all cases into one court, federal judges expect to increase efficiency by all parties involved. 

Plaintiffs who have brought forth lawsuits against these manufacturers allege that they were not adequately warned about the potentially deadly side effects of Xarelto. Many have claimed that they experienced serious gastrointestinal bleeding, blood clots and brain hemorrhaging after taking the anticoagulant. By consolidating these similar cases, the hope is that litigants will be able to combine resources and present them in a more productive way. So far, the four following trial dates have been set for 2016: August 1, August 22, September 12, and October 17. 

Bellwether trials such as these are proposed in order to set examples for future negotiations and settlements between both parties. Given the growing number of Xarelto cases being brought against Janseen and Bayer, these trial cases may be extremely helpful for other patients who wish to seek legal recourse and monetary compensation after being harmed by Xarelto. 

Legal Commentary
Xarelto attorneys within our firm are studying, examining and investigating current Xarelto claims on behalf of people and their families who may have been injured by the drug. Some of the side effects include hemorrhaging, internal bleeding, stroke and or death. If you or a loved one has experienced any side effects while taking Xarelto, contact our Xarelto lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at 1.866.705.7584 or by email at mn@fnlawfirm.com.

About the Author
Majed Nachawati is a dedicated Xarelto Lawyer with a focus on representing victims and families harmed by this dangerous drug on a nationwide basis. Mr. Nachawati has resolved numerous dangerous drug medication cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past six consecutive years for legal excellence, in connection with noteworthy settlements for pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.

 

 

Recent Study Links Xarelto Use to Eye Bleeding

In the recent June 2015 issue of JAMA Ophthalmology, researchers studied some of Xarelto's disturbing side effects, further calling into question the safety of the drug. These scientists studied the link between Xarelto usage and the possibility of an increase in stomach bleeds and eye hemorrhaging. Drs. Judy H. Hun and John C. Hwang found that patients in their 70s and 80s who had taken Xarelto after transitioning from warfarin had experience eye bleeding known as vitreous hemorrhages. 

Because this particular side effect was linked to patients who had transitioned from warfarin to rivaroxaban (the generic of Xarelto), the doctors warn that other clinicians should be made aware of this potential side effect in their patients. Given that more and more doctors are prescribing Xarelto because it requires less monitoring by doctors themselves. However, given studies like these, doctors should be wary of prescribing Xarelto to patients and closely monitor them for any possible side effects. 

Legal Commentary
Xarelto attorneys within our firm are studying, examining and investigating current Xarelto claims on behalf of people and their families who may have been injured by the drug. Some of the side effects include hemorrhaging, internal bleeding, stroke and or death. If you or a loved one has experienced any side effects while taking Xarelto, contact our Xarelto lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at 1.866.705.7584 or by email at mn@fnlawfirm.com.

About the Author
Majed Nachawati is a dedicated Xarelto Lawyer with a focus on representing victims and families harmed by this dangerous drug on a nationwide basis. Mr. Nachawati has resolved numerous dangerous drug medication cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past six consecutive years for legal excellence, in connection with noteworthy settlements for pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.

 

 

More Studies Suggest Xarelto Could Double Risk for Gastrointestinal Bleeding

Xarelto, a relatively new prescription blood thinner, was first approved by the FDA in 2011 for patients who were at risk of developing blood clots as a result of knee or hip replacement surgeries. The marketers of the anticoagulant, Janssen Pharmaceuticals, aggressively marketed the drug as a "one-size-fits-all" drug. Given that, doctors readily prescribed the drug because it didn't require them to monitor their patients as much as other traditional anticoagulants required. Recently, however, several studies have criticized Xarelto for the various dangerous side effects that patients have developed after taking the drug.

One such study, published by the British Medical Journal, suggests that using Xarelto may double the risk of gastrointestinal bleeding compared to the traditional anticoagulant, warfarin. The researchers of this study monitored more than 45,000 patients with the goal of comparing the side effects that develop from taking rivaroxaban (the generic version of Xarelto) and warfarin. Other studies have also suggested that patients who have taken or are taking Xarelto are at a higher risk of internal bleeding. Furthermore, unlike warfarin, Xarelto does not yet have an antidote, meaning that patients who experience internal bleeding must get medical treatment immediately.

Legal Commentary
Xarelto attorneys within our firm are studying, examining and investigating current Xarelto claims on behalf of people and their families who may have been injured by the drug. Some of the side effects include hemorrhaging, internal bleeding, stroke and or death. If you or a loved one has experienced any side effects while taking Xarelto, contact our Xarelto lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at 1.866.705.7584 or by email at mn@fnlawfirm.com.

About the Author
Majed Nachawati is a dedicated Xarelto Lawyer with a focus on representing victims and families harmed by this dangerous drug on a nationwide basis. Mr. Nachawati has resolved numerous dangerous drug medication cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past six consecutive years for legal excellence, in connection with noteworthy settlements for pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.

Foreign Regulators Raise New Questions About Xarelto

Foreign regulators in Australia are questioning whether additional blood monitoring on new anticoagulants would make the drugs safer. These drugs include Pradaxa, Eliquis and more specifically, Xarelto. The Australian Therapeutic Goods Administration recently announced this month that it had completed a review of new oral anticoagulants like Xarelto and have concluded that regular blood monitoring would not improve the drugs. The group came to this conclusion because there is very little usable data from the manufacturers themselves since they have not tested whether monitoring would help patients. 

So far, hundreds of Xarelto lawsuits have been filed against Bayer and Janssen Pharmaceuticals. The drug has been linked to a significant number of complications and negative side effects. Originally, the drug was advertised as a "one-size-fits-all" drug and an alternative to traditional warfarin. However, the drug has no antidote which for patients, can result in uncontrollable bleeding. If not stopped in time, these side effects can be deadly for those taking Xarelto. 

Legal Commentary
Xarelto attorneys within our firm are studying, examining and investigating current Xarelto claims on behalf of people and their families who may have been injured by the drug. Some of the side effects include hemorrhaging, internal bleeding, stroke and or death. If you or a loved one has experienced any side effects while taking Xarelto, contact our Xarelto lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at 1.866.705.7584 or by email at mn@fnlawfirm.com.

About the Author
Majed Nachawati is a dedicated Xarelto Lawyer with a focus on representing victims and families harmed by this dangerous drug on a nationwide basis. Mr. Nachawati has resolved numerous dangerous drug medication cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past six consecutive years for legal excellence, in connection with noteworthy settlements for pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.

 

Xarelto Sales Continue to Rise Even as Patients Continue to Face Complications

Xarelto, the blockbuster anticoagulant that was approved by the FDA in 2011, has recently seen an increase in sales even as the drug continues to cause problems for a significant number of patients. In the first quarter of 2015, both Xarelto sales and J& J pharmaceutical division sales increased by 3% to $7.7 billion. Bayer has increased its forecast for Xarelto's 2015 sales growth to 30% from 20%. Although it's not clear why there has been an uptick in sales, Johnson & Johnson and Bayer have aggressively marketed the drug, which is meant to be an improved alternative to traditional anticoagulants like warfarin. 

Unfortunately, Xarelto has caused numerous medical problems for patients who have been prescribed the drug. Because there is no antidote, patients are at risk of serious bleeding incidents. Additionally, since the drug requires less monitoring by doctors, patients may not know that they are at increased risk of complications until it is too late. The "one-size-fits-all" drug fails to account for individual patient conditions. Recent lawsuits contend that the manufacturers of Xarelto over-marketed the supposed benefits of the drug. So far, there are over 300 federally-filed lawsuits against Johnson & Johnson and Bayer. 

Legal Commentary
Xarelto attorneys within our firm are studying, examining and investigating current Xarelto claims on behalf of people and their families who may have been injured by the drug. Some of the side effects include hemorrhaging, internal bleeding, stroke and or death. If you or a loved one has experienced any side effects while taking Xarelto, contact our Xarelto lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at 1.866.705.7584 or by email at mn@fnlawfirm.com.

About the Author
Majed Nachawati is a dedicated Xarelto Lawyer with a focus on representing victims and families harmed by this dangerous drug on a nationwide basis. Mr. Nachawati has resolved numerous dangerous drug medication cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past six consecutive years for legal excellence, in connection with noteworthy settlements for pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.

Gastrointestinal Effects on Xarelto Worse Than Warfarin, According to New Study

According to a new study published recently by the Johns Hopkins Bloomberg School of Public Health and George Washington University, Xarelto, along with Pradaxa, may pose an increased risk of gastrointestinal bleeding in patients. Patients who instead choose to take warfarin, an older anticoagulant, appear to have a decreased change of experiencing these side effects. The study followed 46,000 patients that were given either Pardaxa, Xarelto or warfarin and watched them for six months. Although this study is preliminary and limited, the results suggest a connection between Xarelto and gastrointestinal issues. 

Xarelto has continued to come under fire because of its side effects. It was originally touted as a "one-size-fits all" drug. Doctors and patients also praised the drug because it did not require the same routine monitoring that warfarin does. However, because of this fact, many doctors may not notice that their patients are having issues with the drug until its too late. Additionally, unlike warfarin, Xarelto does not yet have an antidote, which means that it's essential for doctors to be aware of how their patients are doing. Because of all of these issues and more, lawsuits are being filed by patients who have been harmed by the drug. 

Legal Commentary
Xarelto attorneys within our firm are studying, examining and investigating current Xarelto claims on behalf of people and their families who may have been injured by the drug. Some of the side effects include hemorrhaging, internal bleeding, stroke and or death. If you or a loved one has experienced any side effects while taking Xarelto, contact our Xarelto lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at 1.866.705.7584 or by email at mn@fnlawfirm.com.

About the Author
Majed Nachawati is a dedicated Xarelto Lawyer with a focus on representing victims and families harmed by this dangerous drug on a nationwide basis. Mr. Nachawati has resolved numerous dangerous drug medication cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past six consecutive years for legal excellence, in connection with noteworthy settlements for pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.

Doctors Hesitant About Xarelto For Few Years

In 2012, Reuters published a piece that touched on the hesitancy that some doctors felt about a new generation of blood thinners, one of which was Xarelto. In 2011, the FDA had approved Xarelto for prophylaxis of deep vein thrombosis (DVT) in patients undergoing hip or knee replacement surgeries. A few months later, in November of 2011, the FDA approved it for a second use, for stroke prophylaxis in patients with non-valvular atrial fibrillation. This condition affects about 3 million Americans and Xarelto, a once-daily pill, was meant to decrease the chances that patients with this illness would develop blood clots in a storage chamber of the heart. 

Xarelto has been marketed as a one-size-fits-all solution to traditional warfarin but even in 2012, a year after the drug was approved, doctors were wary of the fact that Xarelto did not require the same amount of monitoring by doctors. If not taken properly, the risk of stroke, serious bleeding and blood clots increases, especially in patients with poor kidney function. Top cardiologists urged other doctors to make sure that patients were adequately tested for kidney function before prescribing Xarelto to their patients.Patients should also be instructed on potentially negative side effects and continue to see their doctors periodically while taking the drug. Unfortunately, in the scramble to prescribe patients this new blockbuster drug, some doctors may have not taking such steps and their patients may have suffered as a result. 

Legal Commentary
Xarelto attorneys within our firm are studying, examining and investigating current Xarelto claims on behalf of people and their families who may have been injured by the drug. Some of the side effects include hemorrhaging, internal bleeding, stroke and or death. If you or a loved one has experienced any side effects while taking Xarelto, contact our Xarelto lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at 1.866.705.7584 or by email at mn@fnlawfirm.com.

About the Author
Majed Nachawati is a dedicated Xarelto Lawyer with a focus on representing victims and families harmed by this dangerous drug on a nationwide basis. Mr. Nachawati has resolved numerous dangerous drug medication cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past six consecutive years for legal excellence, in connection with noteworthy settlements for pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.
 

Increasing Number of Injured Patients Suing Xarelto Around the World

Bayer, the manufacturer of the blockbuster anticoagulant drug, Xarelto, is not only facing a significant number of lawsuits within the United States, but also abroad in other countries. Recently, a number of Canadian citizens have filed claims against Bayer, either on their own behalf or that of deceased family members. According to Toronto lawyer Bryan McPhadden, his firm has filed a lawsuit for the family of a woman who bled to death while taking the drug. Another patient named in the same class action suit alleges that she almost suffered cardiac arrest after developing internal bleeding. Because doctors did not have an antidote, doctors had a very difficult time stopping her bleeding. Additionally, a claim in a German report states that close to 130 deaths have been linked to the drug in 2012 and 2013. 

Xarelto has been aggressively marketed by Bayer as an "all size fits all" anticoagulant. A newer alternative to the traditional warfarin and coumadin, the drug requires less monitoring by doctors. Although on the surface it seems like less monitoring would be less costly and less work for doctor and patient, it also means that patients on the drug who develop negative side effects might not get the medical attention they need in time. Patient may develop uncontrollable internal bleeding and death may result if they do not receive immediate medical care. Therefore, it is unsurprising that more patients and their families around the world are joining class action suits in order to seek compensation for their pain and suffering. 

Legal Commentary
Xarelto attorneys within our firm are studying, examining and investigating current Xarelto claims on behalf of people and their families who may have been injured by the drug. Some of the side effects include hemorrhaging, internal bleeding, stroke and or death. If you or a loved one has experienced any side effects while taking Xarelto, contact our Xarelto lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at 1.866.705.7584 or by email at mn@fnlawfirm.com.


About the Author
Majed Nachawati is a dedicated Xarelto Lawyer with a focus on representing victims and families harmed by this dangerous drug on a nationwide basis. Mr. Nachawati has resolved numerous dangerous drug medication cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past six consecutive years for legal excellence, in connection with noteworthy settlements for pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.

 

 

Should Patients on Xarelto Undergo More Frequent Blood Monitoring?

When Xarelto was first introduced to the general pharmaceutical company, it was touted as a much more convenient alternative to traditional blood thinners like warfarin. The drug was originally prescribed to patients who had undergone knee and hip replacement surgery and who were at a higher risk of blood clots following those procedures. The advantage, Bayer Healthcare claimed, was that patients would not have to be subjected to weekly and inconvenient blood testing while using Xarelto. They aggressively marketed the drug as a "one size fits all" solution to traditional means of blood testing. 

Unfortunately, however, many patients have suffered unfortunate side effects after taking the drug. Because doctors supposedly do not have to regularly monitor their patients on Xarelto, they are not as in tune to how their patients are doing. Many patients on the drug have experienced serious bleeding side effects that include internal and excessive bleeding. Unlike warfarin, Xarelto has no antidote to speak of and patients who experience issues may be at risk of hemorrhaging or death if they do not receive immediately medical care. Although not a perfect substitution, warfarin usage requires that patients undergo regular testing, which could more easily alert doctors to any potential problems before they occur. This undoubtedly brings up the issue of whether doctors who prescribe Xarelto should monitor their patients more frequently in order to prevent any possible complications from arising. 

Legal Commentary
Xarelto attorneys within our firm are studying, examining and investigating current Xarelto claims on behalf of people or families injured by the drug. Some of the side effects include hemorrhaging, internal bleeding, stroke and or death. If you or a loved one has experienced any side effects while taking Xarelto, contact our Xarelto lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at 1.866.705.7584 or by email at mn@fnlawfirm.com.

About the Author
Majed Nachawati is a dedicated Xarelto Lawyer with a focus on representing victims and families harmed by this dangerous drug on a nationwide basis. Mr. Nachawati has resolved numerous dangerous drug medication cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past six consecutive years for legal excellence, in connection with noteworthy settlements for pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.

Xarelto Lawsuits Increasing as More Patients Develop Negative Side Effects

This year has seen a significant increase in the number of law suits being brought against the manufacturers of Xarelto, Johnson & Johnson and Bayer Corp.. Individuals and their families allege that they have faced harmful negative side effects after taking the drug and that Johnson & Johnson and Bayer knew this, but still aggressively marketed their blockbuster drug to consumers. Dozens so far have filed lawsuits in a California federal court. 

When Xarelto was first introduced to the market, doctors and patients quickly flocked to it. Because this particular blood thinner requires little to no monitoring after a patient is prescribed it, it seemed like a great alternative. More traditional anticoagulants require frequently, weekly monitoring by a doctor. However, when patients are monitored more regularly and undergo frequent blood testing, it is easier for a doctor to spot any potential issues more quickly. For that reason, the hands-off approach that occurs after patients begin taking Xarelto puts patients more at risk of internal, uncontrollable bleeding. 

As patients are being made more aware of these potentially deadly side effects, they are increasingly resorting to the courts to seek compensation. In December of 2014, almost two dozen lawsuits were consolidated in Louisiana. In January of this year, there was a creation of a new mass tort in the Philadelphia County Court of Common Pleas. Plaintiffs allege that the manufacturers of Xarelto did not properly warn patients of the potentially deadly complications that could result from taking the drug. 

Legal Commentary
Xarelto attorneys within our firm are studying, examining and investigating current Xarelto claims on behalf of people or families injured by the drug. Some of the side effects include hemorrhaging, internal bleeding, stroke and or death. If you or a loved one has experienced any side effects while taking Xarelto, contact our Xarelto lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at 1.866.705.7584 or by email at mn@fnlawfirm.com


About the Author
Majed Nachawati is a dedicated Xarelto Lawyer with a focus on representing victims and families harmed by this dangerous drug on a nationwide basis. Mr. Nachawati has resolved numerous dangerous drug medication cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past six consecutive years for legal excellence, in connection with noteworthy settlements for pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.

 

Study Reveals That Xarelto-Related Bleeding More Likely in Patients at Higher Risk of Pulmonary Embolism

In the March issue of the medical journal Academic Emergency Medicine, researchers from around the world found a disturbing correlation between the incidence of Xarelto-related bleeding in patients who are already at a higher risk for pulmonary embolism (PE). The study, sponsored by the manufacturers of Xarelto, Bayer HealthCare and Janssen, included about 5,000 patients at risk of pulmonary embolism. What they found was that while Xarelto can be relatively safe for most patients who already have a low to moderate risk of blood clots traveling to the lungs, patients who were at a high risk for pulmonary embolism will face a higher chance of experiencing Xarelto-related bleeding. Researchers found that the incidence in those already facing a higher risk of PE were twice as likely as other patients to experience a bleeding injury while taking Xarelto. 

In other words, it would be advisable for patients with a higher risk of PE to think twice about taking Xarelto. While many doctors prescribe the blockbuster drug because it requires less monitoring on their behalf, they should be alert to this finding and advise their patients accordingly. The drug has recently come under scrutiny for its negative side effects, specifically the risk of uncontrollable bleeding, which could in turn has caused several cases of severe injury and even death. Unfortunately, this particular blood thinner currently does not have an approved antidote to stop uncontrollable bleeding, leaving doctors and patients alike with few solutions or treatments to turn to. 

Legal Commentary
Xarelto attorneys within our firm are studying, examining and investigating current Xarelto claims on behalf of people or families injured by the drug. Some of the side effects include hemorrhaging, internal bleeding, stroke and or death. If you or a loved one has experienced any side effects while taking Xarelto, contact our Xarelto lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at 1.866.705.7584 or by email at mn@fnlawfirm.com.

About the Author
Majed Nachawati is a dedicated Xarelto Lawyer with a focus on representing victims and families harmed by this dangerous drug on a nationwide basis. Mr. Nachawati has resolved numerous dangerous drug medication cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past six consecutive years for legal excellence, in connection with noteworthy settlements for pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.

 

 

For Many Doctors, Xarelto Not Worth the Cost and Side Effects

When Xarelto was first introduced to the market, doctors were quick to prescribe the medication because unlike it's competition, warfarin, it didn't require as much subsequent monitoring by the prescribing doctor. Now, as more individuals come forward and bring new civil law suits against its manufacturer, Bayer and Johnson & Johnson, doctors are become more reluctant to prescribe Xarelto. Both Xarelto and warfarin are anticoagulants that are prescribed to patients after surgery but prescribing warfarin requires that doctors constantly monitor blood levels, which requires regular visits. Xarelto, however, does not require the same constant monitoring, and is seen as a "one size fits all" medication. 

Unfortunately, it's regular monitoring that allow doctors to foresee any possible complications from such medications. Furthermore, Xarelto currently has no antidote. If patients bleed out, it makes it that much more difficult for doctors to reverse the effect. Due to this side effect, several patients have already died or suffered severe bleeding injuries to the lack of an antidote. Additionally, Xarelto, at $250 to $300 a month, is much more expensive than warfarin, which costs as low as 50 cents a day. For many doctors, the benefit of having to monitor their patients less is not worthwhile enough to prescribe Xarelto. 

 

Legal Commentary
Xarelto attorneys within our firm are studying, examining and investigating current Xarelto claims on behalf of people or families injured by the drug. Some of the side effects include hemorrhaging, internal bleeding, stroke and or death. If you or a loved one has experienced any side effects while taking Xarelto, contact our Xarelto lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at 1.866.705.7584 or by email at mn@fnlawfirm.com.

About the Author
Majed Nachawati is a dedicated Xarelto Lawyer with a focus on representing victims and families harmed by this dangerous drug on a nationwide basis. Mr. Nachawati has resolved numerous dangerous drug medication cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past six consecutive years for legal excellence, in connection with noteworthy settlements for pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.

 

Is Medicare Paying Too Much for Acthar?

After Questcor, the pharmaceutical company behind Acthar, was acquired by Ireland's Mallinckrodt, many questions began to be raised about the drug. One was the amount of money that Medicare has been paying for Acthar. In 2008, Medicare covered $141.5 million for the drug and in 2012, it covered around $220 million, increasing by almost double in just four years. Furthermore, in 2012, Medicare accounted for about a quarter of the $761 million in total Acthar sales. 

Some doctors and organizations, however, are skeptical of the relationship between Medicare and Acthar. The drug is frequently prescribed to treat rare kidney diseases and relapses of multiple sclerosis but many doctors are wary of how effective the drug really is. Doctors who have ties to Questcor are also amongst the top prescribers of the drug, and many of those prescriptions are filled out through Medicare. One doctor for example, Mr. William Shaffer, wrote 78 scripts that cost Medicare more than $4 million in 2012. He also routinely gives promotional talks for Questcor, bringing into question a conflict of interest. 

Legal Commentary
Attorneys within our firm are studying, examining and investigating current Acthar claims on behalf of people or families injured by the drug. Some of the side effects include abdominal pain, increase in sugar blood levels and renal failure. If you or a loved one has experienced any side effects while taking Acthar, contact our lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at 1.866.705.7584 or by email at mn@fnlawfirm.com.

About the Author
Majed Nachawati is a dedicated Lawyer with a focus on representing victims and families harmed by dangerous drugs on a nationwide basis. Mr. Nachawati has resolved numerous pharmaceutical litigation cases through trial that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past six consecutive years for legal excellence, in connection with noteworthy settlements for pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.

 

 

Bayer and Johnson & Johnson Push for Additional FDA Approvals on Xarelto, Even as Lawsuits Increase

Last month, it was made known that Bayer and Johnson & Johnson, the companies responsible for manufacturing the blood thinner Xarelto, are pushing for additional FDA approvals for their drug. Xarelto is already being prescribed to patients to treat blood clots, such as deep-vein thrombosis (DVT) and pulmonary embolus (PE), that occur more frequently in patients who have had certain types of surgeries, like knee and hip replacements. Now, the companies want the FDA to approve the use of the drug in stroke patients. 

Bayer and Johnson & Johnson are pushing for this new approval, even after lawsuits against them have already been consolidated against them in two U.S. courts. Currently, Xarelto is leading sales and has captured the largest share of the market, raking in $1.5 billion in sales in 2013 alone. By soliciting more approvals, the companies are essentially attempting to increase profits, even while hundreds of patients hurt by Xarelto are taking legal action against them. A new trial, called the NAVIGATE-ESUS study, will include 7,000 patients and will focus on whether or not Xarelto is a better and safer alternative to aspirin for patients susceptible to strokes. 

 

Legal Commentary
Xarelto attorneys within our firm are studying, examining and investigating current Xarelto claims on behalf of people or families injured by the drug. Some of the side effects include hemorrhaging, internal bleeding, stroke and or death. If you or a loved one has experienced any side effects while taking Xarelto, contact our Xarelto lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at 1.866.705.7584 or by email at mn@fnlawfirm.com.

About the Author
Majed Nachawati is a dedicated Xarelto Lawyer with a focus on representing victims and families harmed by this dangerous drug on a nationwide basis. Mr. Nachawati has resolved numerous dangerous drug medication cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past six consecutive years for legal excellence, in connection with noteworthy settlements for pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.
 

 

Top Prescribers of Acthar Have Ties to Manufacturer, Questcor

Acthar, an expensive specialty drug prescribed to patients with various auto-immune and neurological diseases, has come under scrutiny in recent times for its severe and potentially deadly side effects. It's also recently coming under more criticism because of the relationship many doctors have with its manufacturer, Questcor. 

In 2012 alone, for example, 18 practitioners wrote 15 or more prescriptions for Acthar. At least 9 of those 18 practitioners were promotional speakers, researchers, or consultants for Questcor. Perhaps more importantly, many of those doctors had issues with their medical track records. One neurologist, Dr. Sean Orr, had his license suspended in 2011. Although he was not a top prescriber, he was a promotional speaker for the drug and company. The same doctor was also accused of misdiagnosing healthy patients with neurological diseases in order to prescribe them expensive treatments and medications like Acthar. 

The conflict of interest that these financial relationships reveal is obvious. Doctors have a financial incentive to prescribe the medication, whether a patient may need it or not. Furthermore, at $28,000 for a five-milliliter vial, Acthar is not an inexpensive drug and also generates 95% of Questcor's revenues. 

 

Legal Commentary
Attorneys within our firm are studying, examining and investigating current Acthar claims on behalf of people or families injured by the drug. Some of the side effects include abdominal pain, increase in sugar blood levels and renal failure. If you or a loved one has experienced any side effects while taking Acthar, contact our lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at 1.866.705.7584 or by email at mn@fnlawfirm.com.

About the Author
Majed Nachawati is a dedicated Lawyer with a focus on representing victims and families harmed by dangerous drugs on a nationwide basis. Mr. Nachawati has resolved numerous pharmaceutical litigation cases through trial that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past six consecutive years for legal excellence, in connection with noteworthy settlements for pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.

New Drug May Be Able to Reverse Xarelto's Side Effects

Xarelto is one of the newest blood thinners on the market. It is prescribed to treat patients who are at risk of developing blood clots. However, Xarelto has recently received negative feedback from the pharmaceutical world because of its various side effects, the most common and most negative of them being an increased risk of internal bleeding. Patients who have brought civil lawsuits against the manufacturers, Bayer and Johnson & Johnson, allege that they failed to inform the doctors, patients, and the FDA of the serious side effects and issues.

As of the beginning of January, Portola Pharmaceuticals released information of an experimental drug, called andexanet alfa, which may be able to immediately reverse the anticoagulation activity that can occur in patients taking Xarelto. The development of this antidote has the opportunity to provide vital treatment options for patients who experience major bleeding or require emergency surgery. It's currently in a late-stage study. 

 

Legal Commentary
Xarelto attorneys within our firm are studying, examining and investigating current Xarelto claims on behalf of people or families injured by the drug. Some of the side effects include hemorrhaging, internal bleeding, stroke and or death. If you or a loved one has experienced any side effects while taking Xarelto, contact our Xarelto lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at 1.866.705.7584 or by email at mn@fnlawfirm.com.

 

About the Author
Majed Nachawati is a dedicated Xarelto Lawyer with a focus on representing victims and families harmed by this dangerous drug on a nationwide basis. Mr. Nachawati has resolved numerous dangerous drug medication cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past six consecutive years for legal excellence, in connection with noteworthy settlements for pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.

 

 

Questcor Reveals Numerous Severe Side Effects of Acthar in Filing

Acthar is a prescription gel given to a wide variety of patients who suffer from different ailments. Among them are people with lupus, infants who suffer from infantile spasms, adults who are diagnosed with multiple sclerosis, and for other patients who deal with flares related to various other immune-related disorders. In July of 2014, the manufacturers of Acthar, Questcor Pharmaceuticals, submitted a regulatory filing that brought into question the safety of their drug.

In their filing, Questcor revealed that in 2013, the total number of patients that reported negative side effects after using the drug constituted 14% of prescriptions. As a comparison, in 2011 only 9.1% of prescriptions were reported to have caused issues for patients. Investors use the filings to identity whether a company they want to invest is doing well and they are not investing in a drug that is not harmful to patients. In this case, it was the first time Questcor had made these issues public.

Many of the side effects that were reported by the company were severe or potentially fatal. The drug has since come under scrutiny because of these side effects. The fact that Questcor had not publicly announced these issues speaks to their desire to hide these potentially deadly side effects from investors. Undoubtedly, they have a lot to lose: Acthar, priced at $28,000 for a five-milliliter vial, generates almost 95% of Questcor’s revenues.

 

Legal Commentary
Attorneys within our firm are studying, examining and investigating current Acthar claims on behalf of people or families injured by the drug. Some of the side effects include abdominal pain, increase in sugar blood levels and renal failure. If you or a loved one has experienced any side effects while taking Acthar, contact our lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at 1.866.705.7584 or by email at mn@fnlawfirm.com.

About the Author
Majed Nachawati is a dedicated Lawyer with a focus on representing victims and families harmed by dangerous drugs on a nationwide basis. Mr. Nachawati has resolved numerous pharmaceutical litigation cases through trial that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past six consecutive years for legal excellence, in connection with noteworthy settlements for pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.

 

Xarelto Manufacturers Continue to Pursue FDA Approval Even as Lawsuits Rise

It was recently announced that Bayer and Johnson & Johnson, the manufacturers of Xarelto, will continue to pursue additional FDA approvals for the drug, only this time, for stroke patients. Even as the two manufacturers continue to be hit with lawsuits by consumers who have been injured by the drug, they continue to pursue permission to market the drug for off-label use.

Considering that there are currently hundreds of lawsuits being filed against Xarelto, it would seem like an rash decision by Bayer and Johnson & Johnson to continue to pursue FDA approvals. In December and January, the lawsuits that have been filed against the two manufacturers were consolidated into multidistrict litigation in two U.S. courts, as well as into a mass tort program.

As the lawsuits regarding Xarelto continue to rise, it’s important that consumers be aware of the potential deadly side effects that consumption of the pharmaceutical drug can have. In many cases, patients have been prescribed the blood thinner after knee or hip surgery. Unfortunately, because Xarelto does not yet have an antidote, patients may experience internal bleeding. Thousands of people have thus far been injured by the drug and the number of lawsuits has similarly risen in the past few months.

 

Legal Commentary
Xarelto attorneys within our firm are studying, examining and investigating current Xarelto claims on behalf of people or families injured by the drug. Some of the side effects include hemorrhaging, internal bleeding, stroke and or death. If you or a loved one has experienced any side effects while taking Xarelto, contact our Xarelto lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at 1.866.705.7584 or by email at mn@fnlawfirm.com.


About the Author
Majed Nachawati is a dedicated Xarelto Lawyer with a focus on representing victims and families harmed by this dangerous drug on a nationwide basis. Mr. Nachawati has resolved numerous dangerous drug medication cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past six consecutive years for legal excellence, in connection with noteworthy settlements for pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.
 

JAMA Study Reveals Clinical Trial Misconduct for Xarelto

On February 9th, 2015, JAMA Internal Medicine published an article stating that although the U.S. Food and Drug Administration (FDA) frequently finds problems with the way in which clinical sites perform biomedical research on human participants, this information is hardly ever distributed properly or adequately addressed when trials are published. Scientists who run these trials may be failing to adhere to good clinical practices and the proper research conduct. These violations may include any of the following: a failure to adhere to clinical trial protocols, inadequate or inaccurate record keeping, falsification of reports, or a failure in ensuring the safety of a patient.

Unfortunately, because the FDA has no adequate system in place to communicate these findings to others in the scientific community, other scientists are not properly notified, let alone the general public. Even more astounding is the fact that, out of all these questionable situations, only 4% of these unacceptable conditions and practices are ever revealed. In other words, 3 out of 78 publications actually make clear that within their study, violations were found and what those violations are. For patients, this means that not only are they being treated by a potentially dangerous drug, they may also have no accurate and factual information available to them.

One such case is in regards to the drug Xarelto (generic: rivaroxaban), a blood thinner that has been recently introduced into the pharmaceutical market. Charles Seife, the researcher heading the JAMA study, found that the FDA conducted 16 inspections of the drug and found 8 undisclosed instances of wrongdoing. During these trials, scientists - among other things - falsified data, discarded medical records, and knowingly revealed which patients were receiving the actual drug or a placebo. Although FDA considered the studies unreliable, they were still published, minus the above violations listed.

Unfortunately, even though this new study shows clear problems with the way in which the Xarelto clinical trials were conducted, the drug is still on the market and still harming consumers. The drug, developed and distributed by Johnson & Johnson’s Janssen Pharmaceuticals and Bayer Healthcare, has recently come under fire because of its potentially deadly side effects. The drug is prescribed to patients as an anticoagulant but has no reversal agent. This means that patients are at an increased risk of developing unstoppable internal bleeding that may result in death. If the JAMA study is any indication, it is no surprise that this drug has caused a number of problems for doctors and patients and as such, should not be on the market.


Legal Commentary

Many patients and their attorneys argue that the manufacturers of Xarelto, which include Bayer, Janssen Pharmaceutical and Johnson & Johnson, have withheld information and have not properly warned the public about the risks of this dangerous drug. The above JAMA study only serves to show that the manufacturers of Xarelto have acted negligently in producing this drug. If you or a loved one has fallen victim to any of the side effects of Xarelto, then seeking legal advice may provide you with the ability to hold the manufacturers accountable. Our attorneys have years of experience battling big pharmaceutical corporations. If you would like free legal information about your Xarelto case, call us for a free case evaluation. You can reach us at 1.866.705.7584 or by email at mn@fnlawfirm.com.


About the Author
Majed Nachawati is a preeminent Xarelto Lawyer with a focus on representing Xarelto victims and families harmed by this dangerous drug on a nationwide basis. Mr. Nachawati has resolved numerous cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past six consecutive years for legal excellence, in connection with pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email
 

Xarelto and FDA Approval

Xarelto is an anticoagulant drug approved by the Food and Drug Administration (“FDA”) for three primary uses—to treat patients who are at risk of developing blood clots after knee or hip replacement surgery, to treat those who are at risk of strokes, pulmonary embolism, and deep vein thrombosis and those who are experiencing atrial fibrillation. The Food and Drug Administration did not approve Xarelto to treat all three health conditions at once. The FDA approved Xarelto as treatment for each concern after some research and time.

In July of 2011, the FDA approved Xarelto as a way to reduce the risk of blood clots that may happen after knee or hip replacement surgery. The news release stated that Xarelto should be taken once a day for 12 or 35 days, depending on the type of surgery that was preformed. In November of 2011, the FDA allowed Xarelto to be prescribed to patients who have an abnormal heart beat, also known as atrial fibrillation. Atrial fibrillation occurs when the beatings of the two upper heart chambers are irregular; this leads to blood pooling in the heart’s upper chambers. The pools of blood, or blood clots, travel to the brain and block the blood flow which leads to a stroke. Xarelto can prevent the blood clots, which ultimately prevents the risk of a stroke from occurring. Therefore, the risk of a stroke is reduced in patients taking Xarelto who have atrial fibrillation. In November of 2012, the FDA approved the use of Xarelto to treat deep vein thrombosis and pulmonary embolism. Deep vein thrombosis, also known as DVT, occurs when a blood clot forms in a vein deep within the body. The blood clot has the possibility to break off and travel to an artery in the lungs, blocking the flow of blood. This deadly process is called pulmonary embolism, also known as PE.

To date, thousands of Xarelto lawsuits are filed against the manufacturers and distributors of Xarelto which consist of Bayer, Janssen Pharmaceuticals and Johnson & Johnson, for misleading the public about this dangerous anticoagulant drug. One of the main side effects of Xarelto is severe internal bleeding. There is no effective way to stop the bleeding, which can result in death. The lawsuit alleges that the Xarelto manufactures knew of the potential side effects and knew that there was no treatment, reversal agent or antidote to stop the bleeding.

Legal Commentary

Xarelto attorneys within our firm are studying, examining and investigating current Xarelto claims on behalf of people or families injured by Xarelto. Some of the side effects include hemorrhaging, internal bleeding, stroke and or death. If you or a loved one has experienced any side effects while taking Xarelto, contact our Xarelto lawyers to discuss the facts of your potential case. We are available by phone for a Free consultation at 1.866.705.7584 or by email at mn@fnlawfirm.com.

About the Author

Majed Nachawati is a preeminent Xarelto Lawyer with a focus on representing victims and families harmed by this dangerous drug on a nationwide basis. Mr. Nachawati has resolved numerous dangerous drug medication cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past six consecutive years for legal excellence, in connection with noteworthy settlements for pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.

Xarelto Health Risks

Xarelto is one of the newest blood thinners on the market. The anticoagulant drug is prescribed to patients who have experienced atrial fibulation, are at risk of developing severe blood clots after hip or knee replacement surgery and or to reduce the risk of strokes, pulmonary embolism and deep vein thrombosis. Xarelto is popular because it does not require patients to undergo blood tests to determine the dose and it does not require patients to go in for a routine check-up with their physician. Recently, the health hazards related to Xarelto are alarming; the drug can be fatal by causing abdominal bleeding, hemorrhaging and bleeding in the brain. While most blood thinners on the market have a cure to stop internal bleeding, Xarelto does not. Currently, there is no antidote to stop or reverse the bleeding caused by Xarelto.  Xarelto is designed to stop blood from clotting. There are 13 specific proteins in the blood will start the clotting process. Xarelto is intended to block the protein which prevents the blood clots from forming. This process can be very dangerous if an injury occurs, especially in older adults, because of the possibility of uncontrolled bleeding. Many patients who suffer from severe internal bleeding end up in the hospital, but doctors have no way to reverse the bleeding, which sometimes tragically results in death.

Legal Commentary

Many patients and their attorneys argue that the manufacturers of Xarelto, which include Bayer, Janssen Pharmaceutical and Johnson & Johnson, withheld information and did not properly warn the public about the risks of this dangerous drug. If you or a loved one has fallen victim to any of the side effects of Xarelto, then seeking legal advice may provide you with the ability to hold the manufacturers accountable. Our attorneys have years of experience battling big pharmaceutical corporations.  If you would like free legal information about your Xarelto case, call us for a free case evaluation. You can reach us at 1.866.705.7584 or by email at mn@fnlawfirm.com.

About the Author

Majed Nachawati is a preeminent Xarelto Lawyer with a focus on representing Xarelto victims and families harmed by this dangerous drug on a nationwide basis. Mr. Nachawati has resolved numerous cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past six consecutive years for legal excellence, in connection with pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email

Xarelto Injury Law Firms Selected for Leadership Positions by Judge Eldon Fallon

Xarelto attorney leadership positions have been selected for the Xarelto lawsuits previously filed, consolidated, coordinated and assigned to Judge Eldon Fallon.  Out of 100 Xarelto injury lawsuits filed, Judge Fallon selected a group of plaintiffs’ attorneys to serve in a variety of leadership roles. Judge Fallon appointed twelve attorneys to leadership positions who are charged with various pretrial procedures including, but not limited to conducting discovery, speaking on behalf of plaintiffs at hearings and negotiating prospective settlements with defendants, Bayer, Janssen and Johnson & Johnson. The leadership roles were created to minimize duplicative discovery and to serve all parties involved without conflicting rulings from multiple judges.

Xarelto was approved in July of 2011 by the Food & Drug Administration and is one of the newest blood thinners on the market today. This drug belongs to a class of anti-coagulants that is marketed by both Bayer, Janssen and Johnson & Johnson to reduce the risk and formation of blood clots and stroke, treat deep vein thrombosis and pulmonary embolism, and to reduce the risk of blood clots in patients undergoing hip and knee replacement surgery. While the medication was intended to help, its adverse side effects were seemingly far more dangerous. Unfortunately, the serious and fatal side effects of this drug were not known until after patients began using it. One of the most dangerous side effects for people taking Xarelto includes death caused by uncontrollable bleeding. To date, there is no anti-dote for the bleeding nor is there an effective way to stop the bleeding.

The litigation process is not over, while Judge Fallon has about 100 cases, there are expected to be thousands more Xarelto lawsuits filed throughout the U.S. Since Xarelto litigation is rapidly growing, a selected group of claims will go through the discovery, deposition and trial process to see how juries respond to the cases. Judges can gauge the outcome of other potential Xarelto settlements based on the outcome of the group of claims that went before juries in the U.S. District Court.   

Legal Commentary: The Xarelto lawyers at our firm are currently investigating claims for those affected by Xarelto. From a civil standpoint, our firm has represented thousands of individuals and families who have become victims to Xarelto or its side effects. If you or a loved one has experienced bleeding, blood clots, death or other serious complications while taking Xarelto, contact our pharmaceutical lawyers for a free consultation and case evaluation about your potential Xarelto lawsuit. You can reach us at 866.705.7584 or by email at mn@fnlawfirm.com.

About the Author: Majed Nachawati is a preeminent Pharmaceutical Products Liability Lawyer with a focus on representing Xarelto victims and families harmed by dangerous drugs on a nationwide basis. Mr. Nachawati has resolved numerous cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past five consecutive years for legal excellence, in connection with pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.​

Tylenol Side Effects Links to Liver Damage

Tylenol is the most popular over-the-counter pain relief medication used by millions of people both in the United States and around the world to alleviate ailments such as aches, pain, colds, and fever. Manufactured by Johnson & Johnson, Tylenol contains an active ingredient, acetaminophen, which serves as a painkiller and is used by people of all ages.  Although people have considered Tylenol to be a safe over-the-counter drug for both children and adults, studies indicate the dangers imposed by this common medication. A number of studies have shown that Tylenol is to blame for the leading cause of acute liver failure in the United States. Furthermore, its usage may increase the risk for serious liver damage and poisoning that may lead to liver transplant and even death in some cases. For decades, this drug has been marketed as low risks for consumer, without adequately warning consumers of the serious side effects. The Food and Drug Administration has issued guidelines for the drug maker to include warning labels to their bottles alerting consumers of the potential risks associated with this drug, but did the warning come soon enough? For many, this warning came too late as they have already had to sustain hospitalization and injuries as a result of taking Tylenol. Johnson & Johnson failed to sufficiently warn consumers about the risk of developing liver damage and caused many to suffer as a result.

Legal Commentary:

People don’t normally associate the dangers of drugs such as causing liver failure with over-the-counter medicines since they are typically considered safe and effective, but when you find out that you have sustained serious injuries, what steps do you need to take? If you or someone you love developed liver damage or liver failure while taking Tylenol, you may be entitled to compensation for the injuries you sustained.  It is important for you to explore your legal options by speaking to a qualified lawyer about this dangerous drug. Our experienced team of pharmaceutical lawyers at Fears|Nachawati Law Firm is currently investigating claims to ensure the victims are not burdened by medical expenses and seeks to compensate them for their pain and suffering. For a free attorney consultation, please call 1.866.705.7584 or send an email to mn@fnlawfirm.com.

About the Author:

Majed Nachawati is a preeminent Pharmaceutical Products Liability Lawyer with a focus on representing Tylenol liver failure victims and their families. Mr. Nachawati has been recognized as a Super Lawyer for the past six years in a row and has settled significant settlements for his clients. He is a member of the Texas Trial Lawyers Association, the Million Dollar Advocates Forum and the American Association of Justice. Mr. Nachawati is also a member of the State Bar of Texas Grievance Committee, and is on the Board of Directors for Public Justice. You may be entitled to compensation for the injuries you sustained—if you want to know about your your legal rights, contact Mr. Nachawati at 1.866.705.7584 or by email at mn@fnlawfirm.com for your free legal consultation.

Millions of Men Taking Viagra Are at Risk of Higher Incidence of Melanoma

In June of this year, the Journal of the American Medial Association (JAMA) released a study that linked the usage of Viagra to an increased development of skin cancer, or melanoma. The deadly skin disease is estimated to kill an estimated 9,710 people in the US annually. JAMA derived their data from an experiment that involved more than 25,000 men and controlled for factors such as sun exposure and family medical history. That means that even for men that had no family history of melanoma, they were likely to face a higher occurrence of melanoma after taking Viagra.

The reason behind the linkage, according to doctors, has to do with the way in which Viagra, also known as sildenafil citrate, affects the same pathways that allow cancers to spread aggressively. By analyzing data, doctors and researchers have been able to suggest a strong correlation between the popular medication and the dangerous drug. Now, millions of men have unknowingly made themselves more vulnerable to developing the deadly skin disease.

Legal Commentary
Our experienced pharmaceutical lawyers are currently investigating claims for those affected by melanoma that developed while or after taking Viagra. From a civil standpoint, our firm has represented numerous individuals and families who have become victim to Viagra and its dangerous side effects and the following psychological trauma. If you or a loved one has experienced any of these side effects you should contact one of our attorneys as soon as possible. A successful civil claim pursued against the responsible party will ensure the victims are not burdened with costly medical expenses, and will hopefully compensate them for their pain, suffering, and lost wages for time missed from work. Further questions can be directed to the Fears | Nachawati Law Firm by emailing the lead Viagra lawyer, Majed Nachawati at mn@fnlawfirm.com, or by calling our office at 1.866.705.7584.

About the Author
Majed Nachawati is a preeminent Pharmaceutical Products Liability Lawyer with a focus on representing Viagra victims and families harmed by dangerous drugs on a nationwide basis. Mr. Nachawati has resolved numerous cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice before the Supreme Court of Texas and Arkansas, and is in most federal courts in the nation and holds specific licenses in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past four consecutive years for legal excellence, in connection with pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.​

 

More Doctors Are Now Warning Parents to Stop Using Lidocaine Solutions for Babies That Are Teething

In June of this year, the FDA released a warning to doctors and parents alike about the risk of using lidocaine solutions to numb the pain the babies and toddlers experience while teething. The FDA, along with many doctors, have warned parents to stop using medications that claim to do so as soon as possible. 

A medicated topical numbing gel that comes in either the form of lidocaine or benzocaine is usually used or suggested as babies between the ages of 6 months and 3 year begin to get a new tooth. The medications, however, have been linked to serious side effects or even death. These side effects include seizures, confusion, and heart abnormalities. Furthermore, because the amount used is sometimes difficult to measure, parents usually end up using too much. Given that the medication only works for a few minutes, many doctors now agree that the risk is clearly not worth it. 

The FDA has also previously sent out warnings related to OTC topical benzocaine teething medications, which have resulted in a rare but life-threatening condition called methemoglobinemia. Some OTC benzocaine gels and liquids are sold under brand names such as Anbesol, Hurricaine, Orajel, Baby Orajel, and Orabase.

If you or someone you know has been injured by a product that the FDA later recalled or added strict warnings to, you deserve to understand the full extent of your legal rights and the compensation you may be entitled to receive. In such cases, you may be subject to a pressing statute of limitations (the deadline to make a claim), or you may be at risk of losing evidence critical to your case; therefore, it is essential that you act quickly to preserve your rights. The attorneys at Fears | Nachawati are national leaders in product recall cases and will be happy to assist you. For a free attorney consultation, please call 1.866.705.7584 or send an email to mn@fnlawfirm.com.

Number of Risperdal Lawsuits Rise As Cases of Gynecomastia Increase

In July of 2014, 21-year-old plaintiff Shaquil Byrd sued pharmaceutical company Johnson & Johnson, the manufacturers of the drug Risperdal, in the U.S. District Court for the Northern District of New York. After taking Risperdal, Byrd had developed gynecomastia in which men develop female breasts. He eventually required surgery to remove them. 

Recently, it has come to light that the rare medical condition is associated with the use of the antipsychotic medication. For Mr. Byrd, developing breasts was understandably emotionally and physically painful. He took Risperdal from 2001 to 2008 for mental health issues he was experiencing and did not expect to develop breasts because of the medication. He has had to have multiple surgeries, many of which have left him with physical injuries. 

Although Johnson & Johnson has recently settled a handful of cases before they have gone to trial, the company has pushed back in more recent times. Plaintiffs allege that J&J failed to sufficiently warn about the risk of developing gynecomastia.

Legal Commentary
From a civil standpoint, our firm has represented numerous individuals and families who have become victim to Risperdal’s dangerous side effects and the following psychological trauma. If you or a loved one have taken Risperdal and have experienced abnormal breast growth or milk production we encourage you to consult with one of our Risperdal attorneys as soon as possible. A successful civil claim pursued against the responsible party will ensure the victims are not burdened with costly medical expenses, and will hopefully compensate them for their pain, suffering, and lost wages for time missed from work. Further questions can be directed to the Fears | Nachawati Law Firm by emailing the lead Risperdal lawyer, Majed Nachawati at mn@fnlawfirm.com, or by calling our office at 1.866.705.7584.

About the Author
Majed Nachawati is a preeminent Pharmaceutical Products Liability Lawyer with a focus on representing testosterone replacement therapy victims and families harmed by dangerous treatments on a nationwide basis. Mr. Nachawati has resolved numerous cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bare of Texas. He is licensed to practice before the Supreme Court of Texas and Arkansas, and is in most federal courts in the nation and holds specific licenses in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past four consecutive years for legal excellence, in connection with pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.

 

 

Mary Wasserman and Son File Lawsuit Against Manufacturers of Risperdal

A mother and her son have filed a lawsuit against Johnson & Johnson and Jansseen Pharmaceuticals, the makers and manufacturers of Risperdal. Mary Wasserman, mother to 26-year-old Andrew Wasserman, claims that Risperdal, prescribed to her son after medications failed, caused embarrassing and troubling side effects. Since starting to take the medication, Andrew has developed breasts as part of a condition called gynecomastia. He has had to have a double mastectomy to have the breasts removed.

Rispedral has been approved by the FDA since 1993 to treat several medical conditions, including schizophrenia. It was only in 2007, however, when it was approved for children ages 13-17. It has also been approved to treat bipolar disorder in children ages 10-17 and for children and young adults with autism. However, a study released in 2006 by Duke researchers showed that children who took Risperdal had higher prolactin levels. Higher levels of this hormone promote breast development in women and men but in men, the increase leads to enlarged breasts, difficult producing sperm and decreased sexual ability.

Johnson & Johnson and Janssen Pharmaceuticals recently paid $2.2 billion in November of 2013 to resolve charges regarding the marketing of the drug. The gains made my families through litigation give hope to others that they too can be compensated for the psychological and physical trauma they have endured because of Rispedral.

Legal Commentary
From a civil standpoint, our firm has represented numerous individuals and families who have become victim to Risperdal’s dangerous side effects and the following psychological trauma. If you or a loved one have taken Risperdal and have experienced abnormal breast growth or milk production we encourage you to consult with one of our Risperdal attorneys as soon as possible. A successful civil claim pursued against the responsible party will ensure the victims are not burdened with costly medical expenses, and will hopefully compensate them for their pain, suffering, and lost wages for time missed from work. Further questions can be directed to the Fears | Nachawati Law Firm by emailing the lead Risperdal lawyer, Majed Nachawati at mn@fnlawfirm.com, or by calling our office at 1.866.705.7584.

About the Author
Majed Nachawati is a preeminent Pharmaceutical Products Liability Lawyer with a focus on representing testosterone replacement therapy victims and families harmed by dangerous treatments on a nationwide basis. Mr. Nachawati has resolved numerous cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bare of Texas. He is licensed to practice before the Supreme Court of Texas and Arkansas, and is in most federal courts in the nation and holds specific licenses in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past four consecutive years for legal excellence, in connection with pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.

FDA Adds Severe Warning to Oral Viscous Lidocaine Solutions After Cases of Severe Reactions and Deaths

 
The FDA has released a new warning regarding both prescription and OTC (over-the-counter) oral viscous lidocaine solution, stating that it is not approved to treat teething pain and that health care providers should not prescribe the drug to children with teething pain. The agency now requires that a Boxed Warning, it’s most stringent warning, be placed on the labels of the drug.

The new warning comes after the FDA studied 22 case reports in which infants or young children had serious reactions to oral viscous lidocaine solution. Of those, there were six reported deaths related to the drug. In other cases, when too much lidocaine is used or accidentally swallowed, it can result in seizures, severe brain injury and problems with the heart which may also lead to hospitalization and/or death. As such, the FDA is also requiring that drug companies revise their Warnings and Dosage and Administration sections of drug labels to include the risk of severe adverse events if the drug is prescribed for approved use.

The FDA has also previously sent out warnings related to OTC topical benzocaine teething medications, which have resulted in a rare but life-threatening condition called methemoglobinemia. Some OTC benzocaine gels and liquids are sold under brand names such as Anbesol, Hurricaine, Orajel, Baby Orajel, and Orabase.

The FDA is discouraging parents from giving their children OTC topical medications for teething pain as they have been deemed unnecessary and not useful since it will wash out within a few minutes. Instead, parents should use a chilled teething ring and/or gently rub the child’s gums with a finger to relieve pain.

If you or someone you know has been injured by a product that the FDA later recalled or added strict warnings to, you deserve to understand the full extent of your legal rights and the compensation you may be entitled to receive. In such cases, you may be subject to a pressing statute of limitations (the deadline to make a claim), or you may be at risk of losing evidence critical to your case; therefore, it is essential that you act quickly to preserve your rights. The attorneys at Fears | Nachawati are national leaders in product recall cases and will be happy to assist you. For a free attorney consultation, please call 1.866.705.7584 or send an email to mn@fnlawfirm.com.

 

Doctors Requesting More Research on Link Between Melanoma and Viagra Usage

After a JAMA study released in April of this year found that men who have taken Viagra have an 84% higher occurrence rate of melanoma, more doctors have spoken out, expressing a desire to see more research regarding this link. Dr. June Robinson of Northwestern University’s Feinberg School of Medicine originally wrote an accompanying editorial to the JAMA study which recommended further research to definitively link melanoma risks to the little blue pill. She also cautioned that doctors should be on the lookout for signs of skin cancer in patients that have been prescribed Viagra.

The JAMA study tracked more than 25,000 men around age 65 and found that a significantly higher incidence of melanoma occurred in this group. In particular, they found that if men had ever used Viagra, their risk of developing melanoma was doubled compared to those who had never used it. In the U.S. alone, 76,100 new melanoma cases are expected to be diagnosed this year, with an estimated 9,710 dying from the skin cancer.

Legal Commentary
Our experienced pharmaceutical lawyers are currently investigating claims for those affected by melanoma that developed while or after taking Viagra. From a civil standpoint, our firm has represented numerous individuals and families who have become victim to Viagra and its dangerous side effects and the following psychological trauma. If you or a loved one has experienced any of these side effects you should contact one of our attorneys as soon as possible. A successful civil claim pursued against the responsible party will ensure the victims are not burdened with costly medical expenses, and will hopefully compensate them for their pain, suffering, and lost wages for time missed from work. Further questions can be directed to the Fears | Nachawati Law Firm by emailing the lead Viagra lawyer, Majed Nachawati at mn@fnlawfirm.com, or by calling our office at 1.866.705.7584.

About the Author
Majed Nachawati is a preeminent Pharmaceutical Products Liability Lawyer with a focus on representing Viagra victims and families harmed by dangerous drugs on a nationwide basis. Mr. Nachawati has resolved numerous cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice before the Supreme Court of Texas and Arkansas, and is in most federal courts in the nation and holds specific licenses in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past four consecutive years for legal excellence, in connection with pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.​

 

FDA Requires More General Warning Regarding Potential Cardiovascular Problems on Testosterone Treatment Drugs

The FDA recently announced that they are now requiring a change in the warnings on testosterone products such as Androgel and Androderm. These new warnings are required by law to be more general and warn users of the risk of blood clots. Prior to this announcement, testosterone replacement therapy drugs were only required to include warnings related to polycythemia, a medical issue that occurs due to an abnormally high red blood cell count and that has been linked to testosterone therapy.

This new requirement comes after testosterone therapy treatments were linked to a higher incidence of heart attack, stroke, and other potentially deadly serious cardiovascular problems that are a result of blood clots. Before, companies were only required to include a warning about polcythemia, which although serious, was very specific to certain individuals. The new warning will allow doctors and their patients to better assess whether or not testosterone treatments are the right course of treatment given an individual's own medical and family history of cardiovascular issues. Unfortunately, the requirement comes after hundreds of men have already faced serious health problems or even death as a result of testosterone therapy treatments that they might have otherwise elected not to use. 

Legal Commentary
From a civil standpoint, our firm has represented numerous individuals and families who have become victim to testosterone therapy and its dangerous side effects and the following psychological trauma. If you or a loved one has experienced any of these side effects you should contact one of our attorneys as soon as possible. A successful civil claim pursued against the responsible party will ensure the victims are not burdened with costly medical expenses, and will hopefully compensate them for their pain, suffering, and lost wages for time missed from work. Further questions can be directed to the Fears | Nachawati Law Firm by emailing the lead testosterone therapy lawyer, Majed Nachawati at mn@fnlawfirm.com, or by calling our office at 1.866.705.7584.


About the Author
Majed Nachawati is a preeminent Pharmaceutical Products Liability Lawyer with a focus on representing AndrGel and other similar testosterone therapy victims and families harmed by dangerous drugs on a nationwide basis. Mr. Nachawati has resolved numerous cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice before the Supreme Court of Texas and Arkansas, and is in most federal courts in the nation and holds specific licenses in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past four consecutive years for legal excellence, in connection with pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.​

 

 

Regardless of family history, men who take Viagra at higher risk of developing melanoma

A recent study by JAMA released in April of this year has found that men who take Viagra, the popular drug prescribed for erectile dysfunction, have an shocking 84% risk of developing melanoma, the deadly skin cancer. The study tracked more than 25,000 men who were on average around the age of 65 and who had taken the drug within 3 months.

What they found was that regardless of a family history of skin cancer, these men were more than twice as likely to develop melanoma after taking Viagar. They also accounted for high ultraviolet light exposure and a history of other cancers and still found that Viagra patients had a significantly increased risk of developing melanoma, implying that the drug and not a medical history or environmental exposure was accountable for this serious complication. 

Researchers believe that sildenafil, sold as the drugs Viagra or Revatio, increases the invasiveness of melanoma cells by lowering PDE5A expression, making men who take the drug more vulnerable and susceptible to the skin cancer. Since it was introduced to the market, more than 23 million men have taken the drug. Although the exact number of men affected is currently unknown, JAMA's study has begun the momentum on further studies that will continue the examine the link between melanoma and Viagra usage. 

 

Legal Commentary 

Our experienced pharmaceutical lawyers are currently investigating claims for those affected by melanoma that developed while or after taking Viagra. From a civil standpoint, our firm has represented numerous individuals and families who have become victim to Viagra and its dangerous side effects and the following psychological trauma. If you or a loved one has experienced any of these side effects you should contact one of our attorneys as soon as possible. A successful civil claim pursued against the responsible party will ensure the victims are not burdened with costly medical expenses, and will hopefully compensate them for their pain, suffering, and lost wages for time missed from work. Further questions can be directed to the Fears | Nachawati Law Firm by emailing the lead Viagra lawyer, Majed Nachawati at mn@fnlawfirm.com, or by calling our office at 1.866.705.7584.


About the Author
Majed Nachawati is a preeminent Pharmaceutical Products Liability Lawyer with a focus on representing Viagra victims and families harmed by dangerous drugs on a nationwide basis. Mr. Nachawati has resolved numerous cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice before the Supreme Court of Texas and Arkansas, and is in most federal courts in the nation and holds specific licenses in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past four consecutive years for legal excellence, in connection with pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.comor by calling 1.866.705.7584.​

 

 

Yaz Lawsuits Against Bayer Pharmaceuticals Increasing

As of June of this year, more than 11,000 lawsuits Yasmin and Yaz lawsuits have been filed against Bayer Pharmaceuticals, the makers of the popular birth control. These lawsuits have been filed in the U.S. District Court, Southern District of Illinois and of the 11,677 lawsuits currently filed, 9,055 are currently pending litigation. 

According to court documents and complaints from patients, the birth control has been known to cause deep vein thrombosis, heart attacks, strokes, pulmonary embolisms, gallbladder disease or even death. Although Bayer has not admitted liability so far, the sheer number of health problems that have resulted for numerous women speak to a different reality. 

In a newsletter to stockholders, Bayer has stated that they have spent, as of October 2013, about $1.575 billion to settle 7,600 Yasmin and Yaz lawsuits after experiencing deep vein thrombosis or pulmonary embolisms after taking the birth control. The company has also spent about $24 million to settle lawsuits related to gallbladder issues or injuries. Although the number of lawsuits being brought against the manufacturer is expected to increase in the near future, Bayer has still not held itself liable for not adequately warning women of the potentially deadly risks of taking their drugs. 

If you or a loved one has been injured as the result of taking Yaz or Yasmin, contact Fears | Nachawati today for free legal advice. To speak with one of our Yaz/Yasmin lawyers at no charge, email us or phone us toll free at 1.866.705.7584.

Viagra Usage Linked to Increased Risk of Skin Cancer

After its entry into the pharmaceutical market in 1998, Viagra, the famous "little blue pill", exploded in sales. Today, it's yearly revenue exceeds $2 billion. Unfortunately, the manufacturer of Viagra, Pfizer, is coming under increasing scrutiny as thousands of men are being diagnosed with melanoma, a form of skin cancer, after taking the drug. 

Recent research by JAMA has linked this potentially deadly side effect to the usage of Viagra, suggesting that users may be 84% more likely to develop melanoma. As part of the study, 25,000 men who were taking the drug were followed for ten years. At the end of the study, 142 of those men were diagnosed with melanoma, causing researchers to claim that there was a significant correlation between Viagra and the deadly skin cancer. Pfizer has so far withheld crucial information that would have allowed consumers to make more informed decisions about taking Viagra and the risks associated. Unfortunately, the company's desire to increase profit has come before their consumers' health and well-being. 

Legal Commentary
From a civil standpoint, our firm has represented numerous individuals and families who have become victim to Viagra and its dangerous side effects and the following psychological trauma. If you or a loved one has experienced any of these side effects you should contact one of our attorneys as soon as possible. A successful civil claim pursued against the responsible party will ensure the victims are not burdened with costly medical expenses, and will hopefully compensate them for their pain, suffering, and lost wages for time missed from work. Further questions can be directed to the Fears | Nachawati Law Firm by emailing the lead Viagra lawyer, Majed Nachawati at mn@fnlawfirm.com, or by calling our office at 1.866.705.7584.

About the Author
Majed Nachawati is a preeminent Pharmaceutical Products Liability Lawyer with a focus on representing Viagra victims and families harmed by dangerous drugs on a nationwide basis. Mr. Nachawati has resolved numerous cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice before the Supreme Court of Texas and Arkansas, and is in most federal courts in the nation and holds specific licenses in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past four consecutive years for legal excellence, in connection with pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.​

 

Recent Research Examines Link Between Viagra and Melanoma

JAMA Internal Medicine recently published an article this April that sought to examine the link between sildenafil use and the risk of incident melanoma among men in the United States. Sildenafil is the active ingredient in Viagra, an oral medication approved by the FDA to treat erectile dysfunction and which has been around since 1998. In that time, the drug, which is manufactured by Pfizer, has been prescribed to over 22 million men. 

In its report, JAMA Internal Medicine warned that men who took sildenafil demonstrated an increased risk for melanoma. Although their current results are not enough to change clinical recommendations, Wen-Qing Li, PhD. from Brigham and Women's Hospital cautions that "our data provides epidemiological evidence on possible skin adverse effects of PDE5A inhibitors (sildenafil citrate in Viagra) and support continued investigation of this relationship." Ongoing studies will attempt to better understand the correlation between increased occurrences of melanoma and the use of Viagra.  

Legal Commentary
From a civil standpoint, our firm has represented numerous individuals and families who have become victim to Viagra and its dangerous side effects and the following psychological trauma. If you or a loved one has experienced any of these side effects you should contact one of our attorneys as soon as possible. A successful civil claim pursued against the responsible party will ensure the victims are not burdened with costly medical expenses, and will hopefully compensate them for their pain, suffering, and lost wages for time missed from work. Further questions can be directed to the Fears | Nachawati Law Firm by emailing the lead Viagra lawyer, Majed Nachawati at mn@fnlawfirm.com, or by calling our office at 1.866.705.7584.


About the Author

Majed Nachawati is a preeminent Pharmaceutical Products Liability Lawyer with a focus on representing AndrGel and other similar testosterone therapy victims and families harmed by dangerous drugs on a nationwide basis. Mr. Nachawati has resolved numerous cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice before the Supreme Court of Texas and Arkansas, and is in most federal courts in the nation and holds specific licenses in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past four consecutive years for legal excellence, in connection with pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.​

 

MISLEADING MARKETING TACTICS

Risperdal has been used for years in the treatment of schizophrenia, bi-polar mania, and irritability associated with autistic disorder in children and adolescents.  In addition, Clinical studies involving small numbers of patients have shown some benefit in using Risperidone for stuttering and Tourette's syndrome though these are non FDA-approved uses. Another non-FDA approved use of risperidone is for obsessive-compulsive disorders.

Unfortunately, over the years there have been numerous complaints and claims filed regarding the diverse side effects of the drug. These severe side effects include hyperglycemia and diabetes sometimes leading to death. Another unpleasant side effect would be the development of breasts in young men taking Risperdal.

September 11, 2003 the FDA notified Janssen Pharmaceutica, Inc. (through Johnson & Johnson Pharmaceutical Research & Development, L.L.C.) of the new warning requirement. On November 6, 2003, Janssen submitted supplemental NDAs covering an addition of the information to the Warnings section of the PI for Risperdal. However, instead of notifying doctors and patients in a letter of the additional warning added to the label, they omitted that important material information. This letter minimized the risks and was misleading. The read as follows:

 

“Hyperglycemia-related adverse events have infrequently been reported in patients

receiving RISPERDAL. Although confirmatory research is still needed, a body of

evidence from published peer-reviewed epidemiology research suggests that

RISPERDAL is not associated with an increased risk of diabetes when compared to

untreated patients or patients treated with conventional antipsychotics. Evidence also

suggests that RISPERDAL is associated with a lower risk of diabetes than some other

studied atypical antipsychotics.”

In conclusion it is obvious that Janssen intentionally put consumers at risk and as a result these consumers have suffered. Recently the pharmaceutical company has lost several class action law suits because of their deceptive marketing tactics.

Further questions can be directed to the Fears | Nachawati Law Firm by emailing the lead personal injury lawyer, Majed Nachawati at mn@fnlawfirm.com, or by calling our office at 1.866.705.7584.

The Negative Side of Testosterone Treatments

Lawsuits have been filed claiming that the makers of AndroGel (testosterone treatment) never warned patients and doctors about the cardiac risks associated with the product. There have been claims that men have suffered strokes and heart attacks after using AndroGel.

Even though Abbott Laboratories Inc. knew that testosterone therapies were linked to increased rates of heart attack, stroke and death they chose not to warn patients or doctors. It is said that the reason for not warning the public was profit driven. The lawsuits come just days after the FDA announced that it would be investigating the risk of stroke, heart attack and death in men using prescription testosterone therapies. According to the agency, the investigation was spurred by two recent studies: the first study found that men who were treated with prescription testosterone were 30 percent more likely to suffer from a cardiac event, and the second study found that middle-aged men with a history of heart problems and older men were twice as likely to suffer from a heart attack when undergoing testosterone treatment.

Legal Commentary 

From a civil standpoint, our firm has represented numerous individuals and families who have become victim to testosterone therapy and its dangerous side effects and the following psychological trauma. If you or a loved one has experienced any of these side effects you should contact one of our attorneys as soon as possible. A successful civil claim pursued against the responsible party will ensure the victims are not burdened with costly medical expenses, and will hopefully compensate them for their pain, suffering, and lost wages for time missed from work. Further questions can be directed to the Fears | Nachawati Law Firm by emailing the lead testosterone therapy lawyer, Majed Nachawati at mn@fnlawfirm.com, or by calling our office at 1.866.705.7584.

 About the Author

Majed Nachawati is a preeminent Pharmaceutical Products Liability Lawyer with a focus on representing AndrGel and other similar testosterone therapy victims and families harmed by dangerous drugs on a nationwide basis. Mr. Nachawati has resolved numerous cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice before the Supreme Court of Texas and Arkansas, and is in most federal courts in the nation and holds specific licenses in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past four consecutive years for legal excellence, in connection with pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.comor by calling 1.866.705.7584.​

Allegations That the Side Effects of Lipitor Have Caused Diabetes in Women

Allegations that the side effects of Lipitor have caused diabetes in women, has prompted lawsuits. Lipitor is a cholesterol drug said to reduce the risk of heart attack, stroke, chest pain and certain kinds of heart surgeries in people who have heart disease or several risk factors of heart disease. Women throughout the United States have had similar allegations that they developed diabetes from side effects of Lipitor, and claim that Pfizer has known about the link between Lipitor and diabetes, yet withheld information from consumers and the medical community. This has caused the FDA to require new diabetes warnings for Lipitor and other similar statins, informing users that they may face increased risk of changes to blood glucose levels.

Side-effects of Lipitor are feeling tired or weak, loss of appetite, upper belly pain, dark, amber colored urine, and yellowing of the skin or the whites of the eyes. Additionally, the following side effects have been reported; tiredness, tendon problems and muscle injury, memory loss, and confusion.

Lipitor is one the most widely used brand-name medications in the U.S.

Legal Commentary 

From a civil standpoint, our firm has represented numerous individuals and families who have become victim to Lipitor and its dangerous side effects and the following psychological trauma. If you or a loved one has experienced any of these side effects you should contact one of our attorneys as soon as possible. A successful civil claim pursued against the responsible party will ensure the victims are not burdened with costly medical expenses, and will hopefully compensate them for their pain, suffering, and lost wages for time missed from work. Further questions can be directed to the Fears | Nachawati Law Firm by emailing the lead MESH lawyer, Majed Nachawati at mn@fnlawfirm.com, or by calling our office at 1.866.705.7584.

 

About the Author

Majed Nachawati is a preeminent Pharmaceutical Products Liability Lawyer with a focus on representing Lipitor and other similar statin victims and families harmed by dangerous drugs on a nationwide basis. Mr. Nachawati has resolved numerous cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice before the Supreme Court of Texas and Arkansas, and is in most federal courts in the nation and holds specific licenses in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past four consecutive years for legal excellence, in connection with pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.comor by calling 1.866.705.7584.​

Injured by a Recalled Product?

You may have heard about the recent ignition switch recall by General Motors. http://www.gm.com/ignition-switch-recall.html. Such product recalls are not uncommon and the chances are that you have received a letter at some point in your life informing you that a product you have purchased has been recalled.

If you or someone you know has been injured by a recalled product, merely sending the product back for a replacement or refund is unlikely to be an adequate response. Rather, an individual injured by a recalled product is likely entitled to greater compensation under the law. This likelihood is particularly true because large corporations that produce defective products normally carry large insurance policies for the benefit of the consumers that their products might injure.

If you or someone you know has been injured by a recalled or defective product, you deserve to understand the full extent of your legal rights and the compensation you may be entitled to receive. In such cases, you may be subject to a pressing statute of limitations (the deadline to make a claim), or you may be at risk of losing evidence critical to your case; therefore, it is essential that you act quickly to preserve your rights. The attorneys at Fears | Nachawati are national leaders in product recall cases and will be happy to assist you. For a free attorney consultation, please call 1.866.705.7584 or send an email to mn@fnlawfirm.com.

$9 Billion dollar Verdict against Takeda and Eli Lilly in Actos Trial

Takeda Pharmaceuticals and Eli Lilly hit with a $9,000,000,000.00 billion dollar verdict arising from the sale and distribution of their defective drug, Actos.  Our Actos Lawyers are pleased with the outcome of this case tried by Mark Lanier and we congratulate him and his firm.  Pharmaceutical manufacturers need to be aware of the dangers posed by drugs distributed to consumers--and most importantly, patients need to be warned about these dangers.  

Legal Commentary 

The verdict is staggering and exemplifies what can happen to Corporations that place Profit over the safety of Patients.  The case was presented in part on a Failure to Warn theory, as the warning did not adequately inform users of the risk of developing Bladder Cancer arising from Actos use.  As an Actos lawyer, I believe Takeda should have warned about the danger of Actos induced bladder cancer as soon as they had a suspicion that it may harm consumers--this simply did not happen--and it should have.  As a result of this omission, Takeda and Eli Lilly, companies that manufactured, produced and distributed Actos were taken to task by this Jury and will pay for their wrongdoing by having to deal with a $9,000,000,000 verdict.  The consolidated Actos cases in Louisiana are In Re Actos (Pioglitazone) Products Liability Litigation, 11-md-02299. Allen’s case is Allen v. Takeda Pharmaceuticals North America Inc., 12-cv-00064, both in U.S. District Court, Western District of Louisiana (Lafayette).

About the Author

Majed Nachawati is a preeminent Actos Pharmaceutical Products Liability Lawyer with a focus on representing Actos victims and families harmed by dangerous implantations on a nationwide basis—especially the Actos device. Mr. Nachawati has resolved numerous cases through trials and settlements that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice before the Supreme Court of Texas and Arkansas, and is in most federal courts in the nation and holds specific licenses in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past four consecutive years for legal excellence, in connection with pharmaceutical injury cases. Mr. Nachawati has also been voted as one of only 500 lawyers as one of the Best Mass Tort Lawyers in Dallas by D Magazine. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.

 

Stroke Caused by Low Testosterone Treatment AndroGel

In March there was a complaint filed against the testosterone gel AndroGel by a New York man, Gary White. He joins the growing number of critics and complaints against this treatment for low testosterone (Low T). Gary White used AndroGel and it resulted in him having a stroke after only 5 months of use. Mr. White is a 56 year old man who had no history of heart disease, was in good health, and was living an active lifestyle. Some complaints suggest that the drug makers were “disease mongering.” In other words, it was complained that they had been marketing medications toward symptoms that extend beyond the approved use of the treatment. For example, some marketing suggests that men should seek “Low T” treatment if they feel general symptoms such as fatigue or decreased libido, when in fact these symptoms may be attributed to other medical conditions, such as hypogonadism. It has been alleged that the marketing program attempted to create an idea that a large number of men are affected by low testosterone and that AndroGel is a safe treatment. (See “AndroGel Stroke Lawsuit Filed Over Testosterone Gel Side Effects”)

Legal Commentary
Our firm represents victims of the dangerous and deadly testosterone replacement therapies. If you or a loved one have used testosterone replacement therapies such as AndroGel, Androderm, Testim, Axiron, and others and have experienced cardiac adverse effects, we encourage you to consult with one of our Pharmaceutical attorneys as soon as possible. A successful civil claim pursued against the responsible party will ensure the victims are not burdened with costly medical or funeral expenses. A successful claim will hopefully compensate for pain, suffering, and lost wages for time missed from work. Further questions can be directed to the Fears | Nachawati Law Firm by emailing the lead testosterone replacement therapy lawyer, Majed Nachawati at mn@fnlawfirm.com, or by calling our office at 1.866.705.7584.

About the Author
Majed Nachawati is a preeminent Pharmaceutical Products Liability Lawyer with a focus on representing testosterone replacement therapy victims and families harmed by dangerous treatments on a nationwide basis. Mr. Nachawati has resolved numerous cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bare of Texas. He is licensed to practice before the Supreme Court of Texas and Arkansas, and is in most federal courts in the nation and holds specific licenses in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past four consecutive years for legal excellence, in connection with pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.

Risperdal Lawsuits continue in 2014

On January 28, 2014, the makers of Risperdal, Johnson and Johnson, successfully appealed a verdict rendered in a Risperdal marketing lawsuit filed on behalf of the state of Louisiana. In a 4-3 decision, the Louisiana Supreme Court found that state prosecutors did not prove the company had violated Louisiana law by making misleading claims regarding the safety and efficacy of Risperdal. Consequently, the ruling reverses a $258 million judgment from 2010 against Johnson & Johnson. (Caldwell v. Janssen Pharmaceutical Inc., Civil Action 2012-C-2466)


This ruling comes as other Risperdal lawsuits alleging the use of the medication caused gynecomastia (male breast growth) and other serious side effects continue to move forward in courts around the country. The plaintiffs and potential plaintiffs in these types of lawsuits that allege a connection between Risperdal and gynecomastia, as well as those involving other injuries, should understand that this ruling does NOT impact their claims. Those cases will continue to move forward. Currently, Johnson & Johnson has been named in about 200 Risperdal lawsuits pending in Pennsylvania’s Philadelphia Court Common Pleas that have been filed on behalf of individuals who allegedly developed gynecomastia and other side effects due to the drug.


Moreover, the Louisiana Risperdal lawsuit was just one of several that have accused Johnson & Johnson of improperly marketing the medication. In November 2013, Johnson and Johnson agreed to pay $2.2 million to resolve a similar case involving Risperdal and other drugs that was brought by the U.S. Department of Justice. Among other things, federal prosecutors had accused the drug makers of improperly marketing Risperdal for use in children, and further alleged that the two companies had concealed the link between Risperdal and gynecomastia. (U.S. District Court, Eastern District of Pennsylvania, 04-cv-1529)

Legal Commentary
From a civil standpoint, our firm has represented numerous individuals and families who have become victim to Risperdal’s dangerous side effects and the following psychological trauma. If you or a loved one have taken Risperdal and have experienced abnormal breast growth or milk production we encourage you to consult with one of our Risperdal attorneys as soon as possible. A successful civil claim pursued against the responsible party will ensure the victims are not burdened with costly medical expenses, and will hopefully compensate them for their pain, suffering, and lost wages for time missed from work. Further questions can be directed to the Fears | Nachawati Law Firm by emailing the lead Risperdal lawyer, Majed Nachawati at mn@fnlawfirm.com, or by calling our office at 1.866.705.7584.

About the Author
Majed Nachawati is a preeminent Pharmaceutical Products Liability Lawyer with a focus on representing testosterone replacement therapy victims and families harmed by dangerous treatments on a nationwide basis. Mr. Nachawati has resolved numerous cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bare of Texas. He is licensed to practice before the Supreme Court of Texas and Arkansas, and is in most federal courts in the nation and holds specific licenses in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past four consecutive years for legal excellence, in connection with pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.

Gynecomastia in Young Boys Who Take Risperdal

As Risperdal gynecomastia lawsuits continue to progress in courts all over the United States, one state is taking the initiative to curb the overuse of antipsychotic drugs like Risperdal in children. The initiative is taking place in Ohio and is part of Ohio Minds Matter, an effort by the state to evaluate and improve prescribing of atypical antipsychotics and other psychotropic medications among Medicaid-eligible children, as well as those in foster care.

According to a report published by the Akron Beacon Journal on February 10, 2014, less than 1% of privately insured children are currently treated with antipsychotic medications, compared to 1.3% of children covered by Medicaid. The report also noted that these drugs have the potential to cause serious health problems, including gynecomastia (male breast growth) and diabetes. Among other things, Ohio Minds Matter is aiming for a 25% reduction in the use of antipsychotic medications in children under the age of six.

The launch of the Ohio initiative follows the publication of a Consumer Reports investigation which found that pediatric use of antipsychotics like Risperdal had tripled over the last 15 years. According to an article published by Consumer Reports in December 2013, a disproportionate number of these prescriptions are being written for poor and minority children.

The U.S. Department of Justice announced on November 4th that Johnson & Johnson and its Janssen Pharmaceuticals subsidiary had agreed to pay $2.2 million to resolve criminal and civil charges stemming from their marketing of Risperdal and other drugs. Among other things, the government had accused the companies of concealing the risk of Risperdal gynecomastia and other side effects associated with the medication. Federal prosecutors also claimed that Johnson & Johnson and Janssen had improperly promoted Risperdal for children and elderly dementia patients.

Legal Commentary
From a civil standpoint, our firm has represented numerous individuals and families who have become victim to Risperdal’s dangerous side effects and the following psychological trauma. If you or a loved one have taken Risperdal and have experienced abnormal breast growth or milk production we encourage you to consult with one of our Risperdal attorneys as soon as possible. A successful civil claim pursued against the responsible party will ensure the victims are not burdened with costly medical expenses, and will hopefully compensate them for their pain, suffering, and lost wages for time missed from work. Further questions can be directed to the Fears | Nachawati Law Firm by emailing the lead Risperdal lawyer, Majed Nachawati at mn@fnlawfirm.com, or by calling our office at 1.866.705.7584.

About the Author
Majed Nachawati is a preeminent Pharmaceutical Products Liability Lawyer with a focus on representing testosterone replacement therapy victims and families harmed by dangerous treatments on a nationwide basis. Mr. Nachawati has resolved numerous cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bare of Texas. He is licensed to practice before the Supreme Court of Texas and Arkansas, and is in most federal courts in the nation and holds specific licenses in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past four consecutive years for legal excellence, in connection with pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.

Death Caused By Dangerous Low Testosterone Treatment

AndroGel, a drug used to supplement testosterone which is naturally made by the body. Some men suffer from conditions caused by low testosterone, and the gel is used to aid the lack of natural testosterone. It is a topical hormone gel used simply by rubbing the medication onto the skin. However simple this treatment may seem, the complications it causes are more complex. Information by the federal drug regulatory agency reports at least 42 heart attacks, 44 pulmonary emboli, 18 cerebral vascular accidents and 12 deaths associated with the use of this treatment.

 

Continue Reading...

Best Lawyers in Dallas 2014

Majed Nachawati of Fears | Nachawati Law Firm was selected from a panel of 505 lawyers as one of the "Best Lawyers in Dallas 2014" in the Mass Tort category. Congratulations Mr. Nachawati!

Increased Risk of Heart Failure from Testosterone Replacement Therapies

Testosterone replacement therapy (TRT) has become increasingly more popular each year. In fact, in recent years, the use of popular testosterone treatments such as AndroGel, Androderm, Testim, and Axiron have increased more than a factor of five, and have more than $1.9 million in sales in the year 2012 alone! These treatments are used for men who experience Low Testosterone or “Low T”. The sales of these products are driven by marketing to men who seek treatment for the condition of having little to no testosterone if they feel loss of energy or libido; factors previously considered natural in aging. Studies on these products now show that young men with a history of heart disease and older men who may have had no preexisting conditions or diagnosis of heart disease are 2 times more likely to suffer a heart attack, stroke, pulmonary embolism, or deep vein thrombosis that those who didn’t receive any testosterone treatment. In fact, some data reveals that taking testosterone may increase a man’s overall risk of a heart attack by 36%; a risk which is substantially higher for men over the age of 65.

Legal Commentary
Our firm represents victims of the dangerous and deadly testosterone replacement therapies. If you or a loved one have used testosterone replacement therapies such as AndroGel, Androderm, Testim, and Axiron and have experienced cardiac adverse effects, we encourage you to consult with one of our Pharmaceutical attorneys as soon as possible. A successful civil claim pursued against the responsible party will ensure the victims are not burdened with costly medical or funeral expenses. Although no monetary value can compensate for the death of a loved one who used any of these products, a successful claim will hopefully compensate for pain, suffering, and lost wages for time missed from work. Further questions can be directed to the Fears | Nachawati Law Firm by emailing the lead testosterone replacement therapy lawyer, Majed Nachawati at mn@fnlawfirm.com, or by calling our office at 1.866.705.7584.

About the Author
Majed Nachawati is a preeminent Pharmaceutical Products Liability Lawyer with a focus on representing testosterone replacement therapy victims and families harmed by dangerous treatments on a nationwide basis. Mr. Nachawati has resolved numerous cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bare of Texas. He is licensed to practice before the Supreme Court of Texas and Arkansas, and is in most federal courts in the nation and holds specific licenses in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past four consecutive years for legal excellence, in connection with pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.

Testosterone Law Firm - Nationwide Representation

Testosterone Attorneys at our firm, Fears | Nachawati, continue to review Testosterone Replacement Therapy Cases, known as "TRT," on a daily basis. A number of Testosterone Lawsuits have been filed as a result of two recent studies demonstrating a marked increase in the risk of heart attacks, strokes and death caused by use of Testosterone products such as Androgel, Androderm, Axiron, Bio-T gel, Delatestryl, Dep-Testosterone, Fortesta, Striant, Testim and Testopel. The Testosterone products linked to heart attacks, strokes and death come in the form of gel, patches, injections and in some cases, pills. If you have questions concerning a Testosterone product you are taking, please email the head litigation attorney, Mr. Nachawati, at mn@fnlawfirm.com or call our law firm toll free at 1.866.705.7584. Continue Reading...

Testosterone Stroke Heart Attack and Death Lawyer

Androgel Lawyers and Androgel Law Firm Fears | Nachawati investigates Androgel and Testosterone Lawsuits on a Nationwide Basis 

Testosterone Lawyers and Androgel Attorneys at our firm are accepting Androgel Wrongful Death, Heart Attack, Stroke, Pulmonary Embolism and Deep Vein Thrombosis cases on a Nationwide basis.  To contact our law firm for a free consultation call us at 1.866.705.7584 or email the head lawyer of pharmaceutical litigation at mn@fnlawfirm.com.

Androgel and Testosterone linked to Heart Attack Stroke and Death

The Journal of American Medical Association Study and the PLOSONE study support the widely-held belief for the past ten years that medical data has demonstrated a noticeable increased risk between the use of testosterone containing gels and injections and the increased risk of having a stroke, heart attack or death as a result.  

FDA Alert - Testosterone Study on risk of Heart Attack, Stroke and Death Reports

In the past month, the Food and Drug (FDA) Administration has issued an urgent alert reminding consumers that the side effects are not known of TRT therapy and that they have taken steps to monitor data to determine if there is a causal link between Testosterone Replacement Therapy and an increased risk of heart attack, stroke, and death.

Here is a non-exhuastive list of the products we are investigating and cases we are accepting:

Product                                 Manufacturer

Androgel                              Abbott Laboratories, Inc. and Abb Vie, Inc.

Androderm                          Actives

Axirom                                 Lilly USA, LLC

Bio-T-Gel                             Bio Sante Pharmaceuticals and Teva Pharmaceuticals

Delatestryl                          Indevus Pharmaceuticals

Dep-Testosterone             Pfizer

Fortesta                               Endo Pharmaceuticals

Striant                                  Mipharm S.p.A. and Columbia Laboratories, Inc.

Testim                                  Auxilium Pharmaceuticals and Glaxo Smith Kline, LLC

Testopel                              Auxilium Pharmaceuticals

Androgel and Testosterone Replacement Therapy Lawsuits
 
Our law firm has represented thousands of individuals and families against the world's largest pharmaceutical and medical product device manufacturers.  Our Androgel lawyers are in the process of filing Androgel lawsuits against the manufacturers for negligence, gross negligence, failure to warn, design defect, manufacturing defect, and breach of implied and express warranty.  The damages we are seeking on behalf of our clients include but are not limited to past and future medical expenses, past and future lost wages or loss of wage earning capacity, past and future physical impairment, past and future loss of enjoyment of life, past and future loss of consortium, past and future pain, discomfort and mental anguish, as well as case expenses, costs of court and any other relief a judge and jury believe to be appropriate.  For more information about the legal nuances of the cases, call us at 1.866.705.7584 or email us at mn@fnlawfirm.com

What are your Androgel and Testosterone Legal Options?  Call us for a Free Consultation to Find Out
 
If you or a loved one have taken Androgel, Androderm, Axirom, Axiron, Bio-T-Gel, Delatestryl, Dep-Testosterone, Fortesta, Striant, Testim, or Testopel, and have suffered a stroke, heart attack, pulmonary embolism, deep vein thrombosis or a death, we encourage you to consult with one of our Testosterone attorneys as soon as possible by email at mn@fnlawfirm.com or by phone at 1.866.705.7584.
 
The Super Lawyer heading up the Testosterone Replacement Therapy Lawsuits 
 
Majed Nachawati is the preeminent Pharmaceutical and Medical Products Liability Lawyer with a focus on representing Testosterone Replacement Therapy victims and families harmed by dangerous drugs on a Nationwide basis.
 
Mr. Nachawati has resolved numerous cases through trial and settlement that have resulted in seven and eight figure confidential settlements.  He is on the State Bar of Texas District Six Grievance Committee where as a panelist he oversees complaints and allegations of attorney misconduct in his region.  He represents clients on a nationwide basis and is licensed to practice before the Supreme Court of Texas and Arkansas, and holds specific licenses in the Northern, Southern, and Eastern Districts of Texas, as well as the District of Colorado.  Mr. Nachawati contributes extensively to charitable causes that increase access to justice and remains a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice.  Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past four consecutive years for legal excellence, in connection with pharmaceutical and medical product liability injury cases. Mr. Nachawati is a member of The Million Dollar Advocates Forum that recognizes lawyers for outstanding representation in cases involving settlements or resolutions exceeding $1,000,000.00. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584 to find out what your legal rights are.

 

 

Illegal Kickbacks for Prescribing Risperdal Leads to a $2.2 Billion Settlement

A Johnson & Johnson (J&J) employee, Judy Doetterl, was awarded almost $30 million in whistleblower compensation because she was able to obtain proof that the company J&J had been marketing illegal through kickback schemes in association with the drug Risperdal. Doetterl wore a recording device to one of the company’s marketing presentations. Doetterl and other employees encouraged the government to investigate further into the company because of the certain occurrences they experienced at work. As a result of this investigation, the US Department of Justice pursued charges against J&J for their illegal marketing. The company would allegedly offered kickbacks to doctors if they would push their powerful antipsychotic on patients. This ultimately led to a $2.2 billion settlement agreement to settle the Risperdal claims.

Legal Commentary
From a civil standpoint, our firm has represented numerous individuals and families who have become victim to Risperdal’s dangerous side effects and the following psychological trauma. If you or a loved one have taken Risperdal and have experienced abnormal breast growth or milk production we encourage you to consult with one of our Risperdal attorneys as soon as possible. A successful civil claim pursued against the responsible party will ensure the victims are not burdened with costly medical expenses, and will hopefully compensate them for their pain, suffering, and lost wages for time missed from work. Further questions can be directed to the Fears | Nachawati Law Firm by emailing the lead Risperdal lawyer, Majed Nachawati at mn@fnlawfirm.com, or by calling our office at 1.866.705.7584.

About the Author
Majed Nachawati is a preeminent Pharmaceutical Products Liability Lawyer with a focus on representing Risperdal victims and families harmed by dangerous drugs on a nationwide basis. Mr. Nachawati has resolved numerous cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bare of Texas. He is licensed to practice before the Supreme Court of Texas and Arkansas, and is in most federal courts in the nation and holds specific licenses in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past four consecutive years for legal excellence, in connection with pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.

Risperdal Causes Milk Production and Male Breast Growth in Males

Risperdal—an antipsychotic drug—has negatively affected thousands of men and boys across the country. Many are left with painful and humiliating side effects. In many cases the drug causes males to develop breasts, a condition known as Gynecomastia. In some cases this breast growth also causes them to produce milk. This is because the drug increases the levels of prolactin, the hormone that stimulates the breast development and the milk production. As embarrassing as this is for many young boys and older men, it also leads to frustration because it may also affect sexual function.

Legal Commentary
From a civil standpoint, our firm has represented numerous individuals and families who have become victim to Risperdal’s dangerous side effects and the following psychological trauma. This breast growth and milk production have been said to be the cause of other psychological symptoms which negatively impacts their quality of life. If you or a loved one have taken Risperdal and have experienced abnormal breast growth or milk production we encourage you to consult with one of our Risperdal attorneys as soon as possible. A successful civil claim pursued against the responsible party will ensure the victims are not burdened with costly medical expenses, and will hopefully compensate them for their pain, suffering, and lost wages for time missed from work. Further questions can be directed to the Fears | Nachawati Law Firm by emailing the lead Risperdal lawyer, Majed Nachawati at mn@fnlawfirm.com, or by calling our office at 1.866.705.7584.

About the Author
Majed Nachawati is a preeminent Pharmaceutical Products Liability Lawyer with a focus on representing Risperdal victims and families harmed by dangerous drugs on a nationwide basis. Mr. Nachawati has resolved numerous cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bare of Texas. He is licensed to practice before the Supreme Court of Texas and Arkansas, and is in most federal courts in the nation and holds specific licenses in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past four consecutive years for legal excellence, in connection with pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.

Johnson & Johnson Charged to Pay Fines for Each Prescription Made For Risperdal

Many young boys have been adversely affected by the drug Risperdal. This antipsychotic taken by many young boys has been shown to produce male breasts. This condition, known as Gynecomastia, has caused much psychological trauma in many of the consumers of the drug Risperdal. The company Johnson & Johnson and its Janssen Pharmaceuticals have been accused of hiding the risks associated with this medication. In fact, because of this accusation and other charges in the case State of Arkansas v. Ortho-McNeil-Janssen Pharmaceuticals the state court judge proclaimed a $5,000 fine against the makers of the drug for each Risperdal prescription which was purchased through the state Medicaid program over a 3.5 year period. They were also ordered to pay $2,500 for each of the promotional letters Janssen sent out to doctors in Arkansas to encourage the use of Risperdal among patients; in Arkansas alone, Janssen sent out more than 4,500 letters. In November of 2013 these lead to a total of $2.2 billion to settle with the US Department of Justice. In this settlement, the makers of the drug plead guilty to one criminal misdemeanor charge which involved their illegal promotion of the drug Risperdal as treatment for elderly dementia patients. However, they did not admit to the civil charges over their alleged marketing of Risperdal for pediatric uses.

Legal Commentary
Our firm has represented numerous individuals and families who have become victim to Risperdal’s dangerous side effects, and the following psychological trauma. This male breast growth has been said to be the cause of many psychological symptoms which negatively impacts their quality of life. If you or a loved one have taken Risperdal and have experienced abnormal breast growth, we encourage you to consult with one of our Risperdal attorneys as soon as possible. A successful civil claim pursued against the responsible party will ensure the victims are not burdened with costly medical expenses, and will hopefully compensate them for their pain, suffering, and lost wages for time missed from work. Further questions can be directed to the Law Firm by emailing the lead Risperdal lawyer, Majed Nachawati at mn@fnlawfirm.com, or by calling our office at 1.866.705.7584.

About the Author
Majed Nachawati is a preeminent Pharmaceutical Products Liability Lawyer with a focus on representing Risperdal victims and families harmed by dangerous drugs on a nationwide basis. Mr. Nachawati has resolved numerous cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bare of Texas. He is licensed to practice before the Supreme Court of Texas and Arkansas, and is in most federal courts in the nation and holds specific licenses in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past four consecutive years for legal excellence, in connection with pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.

 

Risperdal Causes Male Breasts in Young Boys

Risperdal, a common antipsychotic drug used for a variety of illnesses, has been seen to have some very negative and damaging side effects in young boys. The drug has been shown to increase the levels of prolactin in young boys thus causing them to develop male breasts, a condition known as Gynecomastia. This video describes the experience of Sam Wilson, a young boy who had developed this condition from his use of Risperdal. Like Sam, many young boys experience fear of humiliation and embarrassment because of the condition caused by this drug. In many cases these young boys are hurt psychologically more than they are helped.

Legal Commentary
From a civil standpoint, our firm has represented numerous individuals and families who have become victim to Risperdal’s dangerous side effects, and the following psychological trauma. This breast growth has been said to be the cause of many psychological symptoms which negatively impacts their quality of life. If you or a loved one have taken Risperdal and have experienced abnormal breast growth, we encourage you to consult with one of our Risperdal attorneys as soon as possible. A successful civil claim that is pursued against the responsible party will ensure the victims are not burdened with costly medical expenses, and will hopefully compensate them for their pain, suffering, and lost wages for time missed from work. Further questions can be directed to the Fears | Nachawati Law Firm by emailing the lead Risperdal lawyer, Majed Nachawati at mn@fnlawfirm.com, or by calling our office at 1.866.705.7584.

About the Author
Majed Nachawati is a preeminent Pharmaceutical Products Liability Lawyer with a focus on representing Risperdal victims and families harmed by dangerous drugs on a nationwide basis. Mr. Nachawati has resolved numerous cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bare of Texas. He is licensed to practice before the Supreme Court of Texas and Arkansas, and is in most federal courts in the nation and holds specific licenses in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past four consecutive years for legal excellence, in connection with pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.

Children Display Psychological Trauma from Taking the Antipsychotic Risperdal

This video describes the story of a young 19 year-old boy named John. He began taking Risperdal when he was 7 for his ADD. Aside from other negative side effects such as aggressiveness, sleepiness, and bowel problems, John developed a condition called Gynecomastia—the growth of female breasts. His Mom mentioned that John even asked her if he was a girl. Unfortunately for many young boys like John who have taken Risperdal, this condition has brought on much grief and sorrow during their young years. Janssen, the company that makes Risperdal, is now being sued for marketing Risperdal for unapproved uses and for downplaying the risks of the medication.

Legal Commentary
From a civil standpoint, our firm has represented numerous individuals and families who are victims of Risperdal’s dangerous side effects, and the following psychological trauma. The breast growth has been said to be the cause of many psychological symptoms which impacts their quality of life. If you or a loved one have taken Risperdal and have experienced abnormal breast growth, we encourage you to consult with one of our Risperdal attorneys as soon as possible. A successful civil claim that is pursued against the responsible party will ensure the victims are not burdened with costly medical expenses, and will hopefully compensate them for their pain, suffering, and lost wages for time missed from work. Further questions can be directed to the Fears | Nachawati Law Firm by emailing the lead Risperdal lawyer, Majed Nachawati at mn@fnlawfirm.com, or by calling our office at 1.866.705.7584.

About the Author
Majed Nachawati is a preeminent Pharmaceutical Products Liability Lawyer with a focus on representing Risperdal victims and families harmed by dangerous drugs on a nationwide basis. Mr. Nachawati has resolved numerous cases through trial and settlement that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bare of Texas. He is licensed to practice before the Supreme Court of Texas and Arkansas, and is in most federal courts in the nation and holds specific licenses in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past four consecutive years for legal excellence, in connection with pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.

Aaron Banks, a 21-Year Old Male Settled With the Drug Company Johnson and Johnson for Understated Risks of Risperdal and its Cause of Male Breast Growth

In September of last year, 21-year old Aaron Banks settled for an undisclosed amount with Johnson and Johnson (J&J) regarding the use of Risperdal with its negative side effects and understated risks. Banks had been treated with Risperdal from the ages 9 to 14. Because of the use of this drug he developed a condition known as Gynecomastia, or the abnormal growth of male breast tissue. Banks’ attorney Stephen Sheller explains that the breast development is caused by the stimulation and increased levels of prolactin—a hormone released by the pituitary gland. Unfortunately for Banks, this growth of males breasts lead to prolonged psychological trauma. This case was only the first of many to follow; recently J&J has been involved in a 2.2 billion dollar Risperdal settlement with the federal government. This law suit is partially based on the alleged understated risks of the medication. Sheller also stated, “There are boys who grew breasts as large as ‘D’ cups. There’s a major design defect here… not just the fact that labeling understated risks.”

Continue Reading...

Death in Dementia Patients Caused by Risperdal Fraudulent Marketing for Unapproved Uses

For more than a decade Risperdal has been promoted for unproven off-label uses. Although doctors may have a legal right to prescribe drugs for some off-label purposes, drug companies are not legally entitled to promote or market drugs for purposes other than those approved by the Food and Drug Administration (FDA). Through salespeople, sent out by Johnson & Johnson (J&J), many drug prescribing facilities were told that Risperdal was commonly used as a miracle drug for dementia and other mental illnesses. Although the FDA reportedly told J&J to discontinue these unapproved, false, and misleading marketing uses on three different occasions, J&J continued promoting it—despite the warnings. Furthermore, while Risperdal was approved as treatment for some mental illnesses by the FDA, dementia was not on the list for approved uses. In fact, Risperdal was shown to increase the chance of death in many dementia patients, but J&J continued to promote Risperdal for dementia, despite these dangerous side effects and continual warnings from the FDA. J&J is now involved in a multi-billion dollar settlement with the U.S. Justice Department because of this fraudulent marketing.

 

Legal Commentary

From a civil standpoint, our firm has represented numerous families who are the victims of Risperdal’s dangerous side effects. The use of Risperdal for off-label purposes has been said to be the cause of many dangerous side effects and psychological symptoms which may impact an individual’s quality of life. If you or a loved one have taken Risperdal for these off-label purposes and have experienced dangerous side effects, we encourage you to consult with one of our Risperdal attorneys as soon as possible. A successful civil claim pursued against the responsible party will ensure the victims are not burdened with costly medical expenses, and will hopefully compensate them for their pain, suffering, and lost wages for time missed from work. Further questions can be directed to the Fears | Nachawati Law Firm by emailing the lead Risperdal lawyer, Majed Nachawati at mn@fnlawfirm.com, or by calling our office at 1.866.705.7584.

 

About the Author

 

Majed Nachawati is a preeminent Pharmaceutical Products Liability Lawyer with a focus on representing Risperdal victims and families harmed by dangerous drugs on a nationwide basis. Mr. Nachawati has resolved numerous cases through trials and settlements that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice before the Supreme Court of Texas and Arkansas, and is in most federal courts in the nation and holds specific licenses in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past four consecutive years for legal excellence, in connection with pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.

Male Breast Growth in Young Boys Because of J&J False Marketing of Risperdal, and Suppressed Information Regarding Risperdone Clinical Trials

 

Would you take a drug if one of the side effects was possible death? Most wouldn’t take that risk. Would you take a drug if you knew that one of the side effects for young men was the risk of breast growth? Few would take that risk as well. However, Risperdal—an atypical antipsychotic medication—has been seen to cause serious and dangerous side effects, such as breast growth and childhood diabetes. These side effects have resulted from promotion of “off-label” purposes such as treatment for young men with ADD, OCD, anxiety, and autism among many others. Many young men who took Risperdal now have a condition called Gynecomastia, or male breast growth. This breast growth in boys has been said to cause negative psychological effects of these young children, negatively impacting their quality of life. These “off-label” uses were promoted by a company Johnson & Johnson, and may also stem from suppressed evidence in early clinical trials of Risperdone—the active ingredient in Risperdal. The hidden data gave evidence to negative outcomes of Risperdone, in some cases, death. The drug has been falsely promoted and J&J has given inadequate warnings of the risks for the consumer and the medical community. In light of these claims, there has been a recent 2.2 billion dollar Risperdal settlement  between Johnson & Johnson and the federal government. Click here to watch a video discussing more about this civil suit. 

Legal Commentary

From a civil standpoint, our firm has represented numerous families who are the victims of Risperdal’s dangerous side effects. Although the use of Risperdal in young boys has not widely resulted in death, the breast growth has been said to be the cause of many psychological symptoms which impacts their quality of life. If you or a loved one have taken Risperdal and have experienced abnormal breast growth, we encourage you to consult with one of our Risperdal attorneys as soon as possible. A successful civil claim that is pursued against the responsible party will ensure the victims are not burdened with costly medical expenses, and hopefully will compensate them for their pain, suffering, and lost wages for time missed from work. Further questions can be directed to the Fears | Nachawati Law Firm by emailing the lead Risperdal lawyer, Majed Nachawati atmn@fnlawfirm.com, or by calling our office at 1.866.705.7584.

About the Author

Majed Nachawati is a preeminent Pharmaceutical Products Liability Lawyer with a focus on representing Risperdal victims and families harmed by dangerous drugs on a nationwide basis. Mr. Nachawati has resolved numerous cases through trials and settlements that have resulted in seven and eight figure confidential settlements. He is on the Grievance Committee for the State Bar of Texas. He is licensed to practice before the Supreme Court of Texas and Arkansas, and is in most federal courts in the nation and holds specific licenses in the Northern, Southern, and Eastern Districts of Texas. Mr. Nachawati is a member of the Board of Directors of the Texas Trial Lawyers Association, the Board of Directors for Public Justice, a Leaders’ Forum and PAC member of the American Association for Justice. Mr. Nachawati has been recognized as a Super Lawyer in Texas Monthly Magazine for the past four consecutive years for legal excellence, in connection with pharmaceutical injury cases. Mr. Nachawati is also a member of The Million Dollar Advocates Forum. Mr. Nachawati can be reached by email at mn@fnlawfirm.com or by calling 1.866.705.7584.

Risperdal Lawyer - Do you have a case?

Risperdal Lawyers and Risperdal Attorneys - Do you have a Case?

Risperdal lawyer evaluations are being conducted and Risperdal and Risperidone cases are being accepted by our Risperdal attorneys on a Nationwide basis.  Risperdal's maker, Johnson & Johnson, is responsible in our opinion for understating the side effects that Risperdal use causes, particularly breast growth in males, known as Gynecomastia.  According to medical studies, Risperdal and or Risperidone use causes an increase in the production of the hormone, Prolactin, which is responsible for causing an increase in breast tissue growth in young males.  Free Risperdone legal advice and free Risperdal consultations are being given by our Risperdal law department on a daily basis.  We represent hundreds of families against Johnson and Johnson and are presently filing Risperdal lawsuits against Johnson & Johnson on a daily basis.  

Continue Reading...

Grieving Mother Calls for Yaz Recall After Daughter's Death

  Katelynne Fisher of Nova Scotia was only 18 years old when she died from a massive stroke caused by a blood clot. She had been taking Yaz, one of the most commonly prescribed birth control pills in the world. Now, her mother, Lisa Fisher, is asking that the popular birth control be recalled from the market. It has recently come to light that at least 23 Candadian women have also died while taking Yaz and Yazmin. Countless other women around the world have also suffered from deep vein thrombosis or a pulmonary embolism, as well as developed issues with their gallbladder.

Yaz and Yazmin, manufactured by Bayer, have been called “newer-generation” birth control pills, as they include a synthetic progestin called drospirenone that is exclusive to this manufacturer. For a woman taking Yaz or Yasmin, the risk of developing a blood clot is 3 in 10,000, much higher than the 1 in 10,000 chance that is associated with taking older birth control pills. With these increased chances, it’s no wonder that Katelynne’s mother is speaking out. She believes her daughter was not properly informed about the greater risks that Yaz carries.

Lisa Fisher has already joined a class action lawsuit against Bayer, who has already paid more than $1 billion to settle lawsuits in the U.S. Fears|Nachawati is currently representing women who have been injured by Yaz. If you or a loved one has suffered injuries like those above after taking Yaz, Yasmin or Ocella, call our office today at 1.866.705.7584 or email us at mn@fnlawfirm.com. We can provide you with the proper legal counsel that you need by your side in your fight against negligent pharmaceutical companies. Call us today! 

Whistleblower Claims Manufacturer of Actos Downplayed Bladder Cancer Risks

Dr. Helen Ge, a medical doctor and former safety consultant for Takeda Pharmaceutical Company, recently blew the lid on the company after they failed to properly disclose evidence that linked use of Actos to an increased risk of bladder cancer. Dr. Ge knew of the connection but when she tried to report it, company officials resisted and downplayed the number. More than 100 bladder cancers were linked to the use of Actos, but only 72 were reported to the FDA. Not only did Takeda Pharmaceutical Co. fail to disclose an accurate number of bladder cancers related to the usage of Actos, they also failed to accurately report to regulators and proper officials about the hundreds of congestive heart failure cases that were associated with taking the drug.

At all turns, Dr. Ge claims, she encountered resistance from superiors when she attempted to report the truth about the potentially deadly side effects that could result from taking Actos. She was forced to underreport or purposely change her assessments, and ultimately, her contract with the pharmaceutical company was terminated.

As Dr. Ge states, “Takeda’s motivation to fraudulently report and under-report the serious adverse events was driven by an economic desire to falsely enhance Actos’s safety profile and to increase sales.” Unfortunately, this has been true for various pharmaceutical companies whose products have similarly endangered the lives of millions of consumers. Patients should feel confident that the medication they are being prescribed will not potentially disable or kill them. If you or a loved one has been prescribed Actos and later developed bladder cancer or congestive heart failure, the attorneys at Fears | Nachawati are here to speak to you about your legal rights and any potential monetary compensation you may be entitled to. Call us at 1.866.705.7584 or email Majed Nachawati at mn@fnlawfirm.com to discuss your potential Actos claim.

Are You Facing an IVC Complication?

An estimated 350,000 Americans have undergone an inferior vena cava (IVC) surgery, allowing a doctor to insert a filter into their blood vessel that’s designed to prevent pulmonary embolism. For most, it’s a procedure that goes off without a hitch. For a notable minority of several hundred, however, complications following an IVC surgery have resulted in severe injury and even death.

 

Whether your IVC complication is the result of someone’s carelessness and whether you may recover under negligence or product liability theories are important questions to ask. Some experts, in fact, believe that IVC manufacturers understood the risks associated with their product better than the doctors and consumers who used them. If that’s the case for you, you may have a valid legal claim.

 

Want to know more about your rights under the law? The attorneys at the Dallas law firm of Fears Nachawati are prepared to advise you. For your free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com. We’re ready to help you!

Understanding the Link between SSRIs and Autism

Selective serotonin reuptake inhibitors (SSRIs), a powerful class of drugs commonly used to treat depression, can have profound, unintended consequences on a child who experiences in utero exposure. According to a recent study, for instance, women who took SSRIs like Prozac, Paxil, or Zoloft were twice as likely to have children with autism spectrum disorder (ASD) and four times as likely to have autism if their mother ingested autism during the first trimester.

 

“What did you know?” and “When did you know it?” These are two particularly important questions in this area of the law. For many women, the act of taking an antidepressant wasn’t necessarily the result of a legal wrong. Taking an antidepressant without being told of its potential side effects, on the other hand, is something altogether different. You deserve full disclosure from the maker of a powerful drug like Zoloft; if you received less than a complete understanding of the risks, you may have experienced a legal harm that entitles you to compensation.

 

Want to find out more about your rights under the law? The attorneys at the Dallas firm of Fears Nachawati are prepared to answer your questions and advise you of your rights and responsibilities under the law. For your free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com. We’re ready to help you.

The Full Scope of Pradaxa Liability

Many patients assume that the maker of Pradaxa, the powerful blood-thinner that has been prescribed to thousands of patients, is only responsible for the production of the drug that caused their internal bleeding. This isn’t necessarily the case. In many defective drug or defective medical product lawsuits, the maker is not only legally responsible for the way a product was made, but also how it was designed and marketed.

 

If you’re like the thousands of Americans who have reported Pradaxa adverse events to the U.S. Food and Drug Administration (FDA), you may want to carefully explore the full scope of Pradaxa liability. By asking questions about design and marketing as well as production, you may find important answers to your case – and to the liability associated with your injury.

 

Want to learn more about your rights under the law? The attorneys at the Dallas law firm of Fears Nachawati have years of experience helping defective drug victims like you. Get started with your recovery by talking to us today. For your free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com. We’re ready to help you.

Transvaginal Mesh Claims: Individual Filing or Class Action?

If you, your spouse, or your loved one has suffered pain, infection, or discomfort following a transvaginal mesh (TVM) surgery, you may be curious to know whether you should file a lawsuit and, if so, whether you should join in a class action case.

 

The only way to answer this question with absolute certainty is to speak with the attorneys and dedicated professionals at the law firm of Fears Nachawati. Nevertheless, there is a general rule worth considering: when the severity of an injury varies, a class action may not be best. Class actions are effective legal tools when a group of people has sustained precisely the same type of injury. In the context of TVM surgeries, however, patients’ injuries often vary, meaning that a class of litigants cannot form as easily. As such, it may be best to go it alone, despite the cost benefits of a class action.

 

Want to find out more about the legal strategies that may be available to you and your family following a painful or ineffective TVM surgery? The attorneys at Fears Nachawati are prepared to answer your questions and start you on your road to legal recovery. For your free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com

How Can a Lawyer Help You with Your Prozac Lawsuit?

Thousands of families have been surprised to learn that their newborn came into the world having suffered a medical injury caused by a careless drug manufacturer. The sad irony for many families is that the womb in which the child was being carried, the part of his or her mother most closely associated with safety and protection, was the place where he or she was injured.

 

In an effort to combat natal depression, some expecting mothers take antidepressants such as Prozac, Lexapro, or Zoloft without realizing the possibility that their child may be hurt in the process. If your newborn suffers from persistent pulmonary hypertension (PPHN) or one of several cardiac, behavior, or physical conditions, your family may have suffered a legal wrong. As with all legal wrongs, you may be able to successfully avail yourselves of your legal rights and remedies.

 

An experienced attorney with the Dallas law firm of Fears Nachawati may be able to help you understand your options in the aftermath of your family’s Prozac or other SSRI-related injury. With years of experience, we’re prepared to advise you on the many challenges you face and guide your thinking as to what your next steps should be. For your free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com

NuvaRing Side Effects, NuvaRing Lawsuits

NuvaRing’s side effects are more extensive than many patients realize. While blood clots are perhaps the most widely reported problems associated with NuvaRing, other related side effects include deep vein thrombosis (DVT), pulmonary embolism, heart attack, stroke, toxic shock syndrome, and cerebral hemorrhage.

 

The physical pain and emotional suffering you or your family has experienced as a result of NuvaRing may entitle you to legal relief. Sadly, many NuvaRing patients were never informed of the risks associated with this powerful medication. As a result, they experienced personal injury without the opportunity to make a meaningful choice about how much risk they bore.

 

A NuvaRing lawsuit may be appropriate in light of the NuvaRing side effects you’ve experienced. To find out what your next steps should be, talk to the professionals at the law firm of Fears Nachawati. For your free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com. We’re ready to give you the advice you need.

Was Your IVC Filter Defective?

In the last decade, the makers of inferior vena cava (IVC) filters have been aware of documented medical studies outlining the concerns about defective filters. Despite this awareness, they continued to design, market, and produce filters that posed patient risks such as death, hemorrhage, severe pain, and perforation of internal tissues.

 

Have you been injured as a result of a defective IVC filter? If the answer is yes, you may have experienced not only a medical injury but a legal injury entitling you to lost wages, pain and suffering damages, and compensation for your health care expenses. The attorneys at the Dallas law firm of Fears Nachawati know how to help you. For your free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com

Did You Know You Took a 1-in-10 Chance on an Injury?

According to the U.S. Food and Drug Administration (FDA), of the roughly 300,000 women who received transvaginal mesh (TVM) implants in 2010, one-in-ten experienced severe complications within the first year of surgery.

 

Dangerous medical procedures are common. Frequently, patients find themselves between the rock and hard place of choosing between a potentially fatal illness and a potentially harmful medical procedure. Of course, there’s a world of difference between this situation – in which patients give informed consent – and the facts at issue with TVM procedures.

 

Most of the women who underwent a TVM procedure had no idea that the risk of collateral injury was as high as ten percent. Consequently, they experienced risk of harm with consenting to it. For the estimated thirty thousand women who encountered physical pain and emotional suffering, their legal rights may have been violated as a result.

 

Want to know whether your TVM experience was a violation of your legal rights that entitles you to financial compensation? The attorneys at the Dallas law firm of Fears Nachawati can help you answer this critical question. To find out what you need to know, contact our professionals today. For a free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com. We’re ready to give you the advice and support you need.

Why Actos Lawsuits May Top 10,000 Nationwide

The number of filed Actos (pioglitazone) lawsuits is on pace to pass the 10,000 mark, according to some legal analysts. The rise in filings is attributed to the dramatic findings of a few key surveys.

 

The manufacturer of Actos recently announced the mid-period findings of its ten-year review of the drug. The scientists’ verdict was that patients who took Actos for longer than one-year experienced a forty percent higher probability of developing bladder cancer. Additionally, the U.S. Food and Drug Administration (FDA) concluded that the possibility for congestive heart failure was sufficiently high to justify a black-box warning.

 

The reason that Actos filings are trending upwards isn’t simply because the findings came to light. It’s that these findings came to light years after Actos was first released onto the market in 1999 and before the drug manufacturer was sufficiently warning the public and health care providers about the risk of harm.

 

Want to know whether filing an Actos lawsuit is right for you or your family? Talk to the professionals at Fears Nachawati today. With years of experience and dedicated expertise, we know how to advise you properly. For your free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com. We’re ready to fight for your rights.

When Is the Right Time to Settle Your Pradaxa Claim?

Pradaxa is a powerful drug designed to thin a patient’s blood and, in turn, reduce the risk or prevent the occurrence of blood clots. That’s what the maker of this pharmaceudical product has been quick to tell the public. What Pradaxa’s manufacturer has been slower to communicate is the fact that within 6 months of its release, the FDA received more than 500 reports of internal bleeding or death.

 

For many patients and their families, the detrimental health effects of Pradaxa have given rise to valuable legal claims. Some have even filed lawsuit against the responsible drug maker, fighting for a chance at justice and compensation.

 

If this sounds familiar to you, there’s a question to which you need to know the answer: when is the right time to settle. For some families, there is no right time. They want to pursue litigation all the way until they reach a jury verdict and, if appealed, an appellate decision in their favor. For many other victims, there’s a careful balancing that must occur. How long should litigation go on? How many months or years do I want to give to this process? When have I secured justice for my loved ones?

 

Need help sorting through these and other questions related to Pradaxa? The attorneys at the Dallas law firm of Fears Nachawati are prepared to help you through this process. Contact us today to get started. For your free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com. We’re ready to work with you.

Was Your Husband Injured by Your Transvaginal Mesh?

Typically, transvaginal mesh (TVM) injures women. Not only does TVM sometimes fail to solve the problems it was intended to solve – usually, pelvic organ prolapse (POP) or stress urinary incontinence (SUI) – but medical reports suggest that it causes new and additional health issues, including infection, subsequent remedial surgeries, and chronic pain. Food and Drug Administration (FDA) medical reports place the annual number of in the hundreds.

 

To the surprise of many, TVM surgeries have also injured some men, too. During the act of sexual intercourse, men have reported suffering cuts, abrasions, and debilitating pain caused by an eroding vaginal mesh. Some men have even encountered serious injuries to their urethra and damage to blood vessels.

 

If you or your partner has experienced TVM injuries, you may want to consider asking whether your rights were violated and, as a result, you have a valid claim to a legal remedy. The attorneys and dedicated professionals at Fears Nachawati can help you answer these and other important questions about the legacy of your TVM procedure. For your free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com

Has Your Child Suffered an SSRI Birth Defect?

The birth defects related to selective serotonin reuptake inhibitors (SSRIs) are numerous, painful, and life-altering. If your child has suffered from a cardiac birth condition, such as tetrology of fallout, hypoplastic left heart, or septal defect, or from a non-heart-related birth defect, such as spina bifida, cleft palate, or club foot, you may want to consider visiting with not only medical professionals, but legal counselors, too.

 

The law protects the victims of a personal injury, including injuries that occur to infants before their birth. The size of a legal recovery and the amount of time spent in litigation can vary, but what is unchanging is that a patient and victim must successfully allege certain factual and legal realities if the plaintiff is to succeed.

 

What are those realities? What might separate you and your family from the kind of sizeable financial recovery capable of off-setting your medical costs? The attorneys at the Dallas law firm of Fears Nachawati know these factual and legal issues well and can give you the advice and direction you need to successfully pursue your claims. For your free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com

Why Nationwide Experience Matters in IVC Cases

Inferior vena cava (IVC) filters have been designed, manufactured, and marketed by major pharmaceudical companies like C.R. Bard, Inc., Boston Scientific Corporation, and Cook Group, Inc. And in communities across the country, these filters have caused personal injury as a result of the tendency of IVC filters to migrate, disintegrate, and embolize. With products originating in states like New Jersey, Massachusetts, and Indiana and with injuries occurring in any number of states, a legal challenge emerges: what’s the appropriate place to file a lawsuit and which state’s law should apply?

 

Many firms are not experienced at handling interstate litigation. Of course these attorneys can learn, but if you already feel like the medical community’s guinea pig, you’re probably not interested in being a first case for a local attorney looking to practice law on a bigger stage.

 

Do you need experienced, dedicated legal counselors who are familiar with the challenges of pursuing complex medical product liability litigation? The attorneys at the Dallas law firm of Fears Nachawati are prepared to help you through these difficult issues. A free consultation with our professionals is just a phone call away. Call us at 1.866.545.8364 or email mn@fnlawfirm.com. We’re ready to fight for your rights.

The Relative Risks of NuvaRing and Traditional Contraceptives

Tragically, many NuvaRing patients decided to try this powerful, internal contraceptive without understanding the relatively greater risk associated with this medical product. Some have suffered medical consequences and, as a result, they or their close relatives may avail themselves of their rights and secure a legal remedy.

 

In the last twenty-four months, leading medical organizations, including the U.S. Food and Drug Administration (FDA) and the New England Journal of Medicine, have revealed medical research that NuvaRing vaginal rings can almost double the risk that a patient will develop a blood clot when compared to traditional oral contraceptives.

 

These findings, coupled with the fact that more than 1 million women use NuvaRing, have raised a series of important questions that victims are asking of the maker of this drug. For the manufacturer of this potentially defective health product, the questions are what did you know, when did you know it, and did you appropriately communicate what you knew to health care professionals, your patients, and the general public?

 

Would you like to know the answers to these questions and more? Have you or has someone in your family been hurt by a NuvaRing prescription? Find out whether the medical event you’ve experienced gives rise to a legal and financial remedy. Talk to the lawyers and dedicated professionals at Fears Nachawati today. For a free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com. We’re ready to advise you.